Abstract
The human oral cavity is a diverse ecological niche favorable for colonization by hundreds of different species of microorganisms. They include not only bacteria but also numerous species of fungi, many of which are able to cause opportunistic infections when the host’s immunity is impaired, predominantly by systemic and chronic diseases like diabetes, pulmonary diseases, renal disorders, or acquired immunodeficiency syndrome. Within the dental biofilm and subgingival sites, fungi of the genus Candida are often found, also in individuals affected with periodontitis. Moreover, fungal species of other genera, including Malassezia, Aspergillus, Penicillium, and Rhodotorula were identified in the oral cavity as well. The wide range of various virulence factors and mechanisms displayed by fungal pathogens allows them effectively invading host tissues during periodontal infections. These pathogenicity-related mechanisms include firstly the fungal ability to adhere successfully to the host tissues closely related to the formation of hyphae, the increase in the surface hydrophobicity, and the surface display of a wide variety of adhesins. Further mechanisms include biofilm formation and secretion of an armory of hydrolytic enzymes and toxins enabling the attack on host cells, modulation of the local inflammatory state, and evading the host immune system. In the pathogenesis of periodontitis, the significant role of fungal co-existence with key bacterial periodontopathogens has been demonstrated, and such interactions were primarily confirmed for Candida albicans and Porphyromonas gingivalis, where the presence of fungi ensured the survival of strictly anaerobic bacteria under unfavorable aerobic conditions. However, several other mechanisms, including those related to the production of quorum sensing molecules, might also be indicated as particularly important for synergistic or antagonistic interactions with a variety of bacterial species within mixed biofilms. These interactions constitute an extraordinary challenge for applying effective methods of combating biofilm-related infections in the periodontium without the risk of the development of drug resistance, the recurrence of disease symptoms, and the progress of life-threating systemic complications.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
FormalPara Highlights-
Several fungal species from genera Candida , Rhodotorula, Penicillium, Aspergillus , and Malassezia belong to the human oral microbiome and some of them may be important in the pathogenesis of periodontitis
-
Conditions associated with decreased immunity may lead to the development of periodontal disease associated with the presence of fungi in subgingival sites
-
Several fungal virulence factors, including adhesins, toxins, and hydrolytic enzymes, may contribute to the development of periodontitis
-
The coexistence of fungi with key bacterial periodontopathogens within the periodontium may affect the pathogenesis of periodontitis
-
The documented relationship between periodontal diseases and a healthy lifestyle confirms that proper oral hygiene and smoking cessation may increase the chances of long-term oral health
-
Controlling and systematically removing the biofilm from supragingival sites is an effective method of maintaining healthy gums
-
In patients with chronic diseases like diabetes mellitus, chronic pulmonary diseases, or chronic kidney diseases, the prevention and treatment of periodontitis should be planned individually
The most common periodontal diseases are caused by various species of bacteria that colonize the oral cavity along with a broad spectrum of fungal pathogens. Bearing in mind the noticeable role of fungi in the pathogenesis of periodontal diseases, the effective treatment should consider the increased resistance of mixed subgingival dental biofilm to antibiotics and antimycotics. The use of appropriately selected therapy increases the chances of a complete cure for periodontal diseases and reduces future recurrence risk.
1 Fungal Species as a Part of the Microbiome of the Human Oral Cavity
The human oral cavity has one of the most diverse microbiomes , comprising about six hundred species of bacteria and about one hundred fungal species (Ghannoum et al. 2010; Dewhirst et al. 2010; Baumgardner 2019). Its humid, warm, and nutrient-rich environment is divided into several niches, including the tongue, cheeks, palate, tonsils, gingival pockets, teeth, and saliva, which enable the coexistence of numerous microorganisms within the complex and protecting structure which is a biofilm . A well-known example is a dental biofilm in which various bacterial species may collectively coexist and form communities both above the gingival line (supragingival sites) and below the gingival line (subgingival sites) (Könönen et al. 2019). Collaborating, they can modulate the host’s defense response, thus ensuring successful colonization associated often with the development of two of the most common oral cavity disorders—caries and periodontitis (Marsh 2006; Murakami et al. 2018; Valm 2019).
Contrary to bacteria, fungal microbiome profile has been so far poorly characterized in particular with regard to species belonging to genera other than Candida . Furthermore, their presence in the oral cavity is often limited to diseases associated with mucosal infections (Hellstein and Marek 2019). The first study characterizing the fungal microbiome in healthy people’s oral cavity was presented a decade ago and identified 101 species of fungi from oral wash samples using molecular biology methods (Ghannoum et al. 2010). The most frequently isolated genera were Candida , Cladosporium, Aureobasidium, Saccharomycetales, Aspergillus , Fusarium, and Cryptococcus. The later studies additionally indicated Penicillium, Schizophyllum, Rhodotorula, and Gibberella as fungi commonly found in the oral cavity of healthy people (Monteiro-da-Silva et al. 2014; Peters et al. 2017).
Despite the widespread use of oral hygiene products, the periodontal disease remains one of the most common diseases affecting adults and children (Kinane et al. 2017). Supragingival microbes are responsible for the mild course of gingivitis, and root caries disease. Subgingival species accelerate the destruction of the tissues that support the teeth and might cause severe periodontitis (Shi et al. 2018a; Könönen et al. 2019). The main species in the supragingival sites are Candida , Malassezia, Cryptococcus, Saccharomyces, Trichoderma, and Cladosporium, but their abundance fluctuates when caries occurs (Fechney et al. 2019; Baraniya et al. 2020). Despite the diverse microbiome of individual niches in the oral cavity, the only species isolated from the subgingival sites of healthy individuals were Candida albicans and C. dubliniensis (Reynaud et al. 2001; Urzúa et al. 2008; Canabarro et al. 2013; Babitha et al. 2018), which suggests that periodontal pockets are not a favorable site for fungal microorganisms (Urzúa et al. 2008; Jewtuchowicz et al. 2008). However, in patients with chronic periodontitis, C. dubliniensis, C. parapsilosis, C. tropicalis, and C. glabrata were abundantly isolated (Babitha et al. 2018; De-la-Torre et al. 2018), but there was no correlation between the degree of colonization and the depth of periodontal pockets (Babitha et al. 2018). Moreover, species such as C. parapsilosis, C. dubliniensis, C. tropicalis, and Rhodotorula spp. have been identified in the subgingival biofilm of patients with severe chronic periodontitis but always as associated with C. albicans (Canabarro et al. 2013). The diversity of fungal communities in the oral cavity is summarized in Table 6.1.
2 Factors Predisposing to Fungal Infections in the Periodontium
Among several factors predisposing to the development of periodontitis associated with an oral fungal infection should be considered specific genetic conditions, primarily increasing the susceptibility of particular individuals to the progression of this inflammatory-related infectious disease. However, other risk factors are important, including acquired systemic diseases that weaken the human organism’s ability to defend against oral opportunistic pathogens. The specific environmental risk factors should not be underestimated either (Fig. 6.1) (Page and Kornman 1997; Johansson and Dahlén 2018).
One of the main medical conditions that might contribute to the onset or exacerbation of pre-existing symptoms of fungal-related periodontal disorders is the infection with the human immunodeficiency virus (HIV) and the subsequent development of acquired immunodeficiency syndrome (AIDS) (Aas et al. 2007). The analysis of samples taken from HIV-positive patients with periodontal lesions showed intense colonization of the oral cavity by yeasts C. albicans and S. cerevisiae (Aas et al. 2007).
The development of periodontal disease may also be influenced by cancer diseases leading to general immunosuppression. Qualitative and quantitative changes in the oral microbiome have been reported in patients with hematological neoplasms, where, in addition to C. albicans, have been found other Candida species—C. glabrata, C. tropicalis, C. krusei, C. parapsilosis or C. kefyr (Schelenz et al. 2011; Aslani et al. 2018).
The incidence of prolonged inflammation related to periodontitis has been frequently reported as associated with chronic systemic diseases, and the observed relationship was often suggested to be bidirectional, where the occurrence and severity of one condition correlated with an increased risk of the other disorder (Wahid et al. 2012; Casanova et al. 2014; Hou et al. 2017). Although more extensive research on this issue is still required due to the high heterogeneity of the previously reported studies, the interdependence of periodontitis and diabetes mellitus, chronic pulmonary diseases, or chronic kidney diseases has been suggested so far (Taylor et al. 2004; Shi et al. 2018b; Zhao et al. 2018; Kapellas et al. 2019; Norhammar et al. 2019). Under such concomitant conditions weakening the immune system, Candida yeasts were often identified within the group of microorganisms isolated from the subgingival dental biofilm in individuals suffering from periodontitis (Javed et al. 2009; Bastos et al. 2011; Sardi et al. 2012a; Matić Petrović et al. 2015). In the case of patients with well-controlled and poorly controlled diabetes mellitus, both the most common Candida species—C. albicans—and other species of the genus, including C. glabrata, were isolated from periodontal tissues affected by inflammation (Melton et al. 2010; Hammad et al. 2013). It was also previously reported by Sardi et al. (2011b) that patients with co-morbid chronic periodontitis and diabetes showed greater colonization of the periodontal pockets and furcation sites by various species of the genus Candida , with the predominance of C. dubliniensis and C. albicans, in comparison to non-diabetics. Also, in these studies, two other Candida species—C. tropicalis and C. glabrata—were identified in subgingival biofilm exclusively in diabetic patients (Sardi et al. 2011b). Other studies also indicated that the prevalence of Candida species in subgingival sites was higher in diabetics with poor glyco-regulation, and the most frequent species isolated from subgingival areas in such patients was C. albicans followed by C. glabrata and C. tropicalis (Matic Petrovic et al. 2019). Furthermore, it was also shown that in the case of patients with chronic kidney disease, periodontitis was characterized by greater severity and increased frequency of C. albicans and red-complex bacteria, compared with a control group of patients (Bastos et al. 2011).
Other factors that increase periodontal disease risk are dental procedures, such as endodontic treatment, which expose recessed dental structures. The most commonly isolated species from infected root canals were C. albicans, R. mucilaginosa, C. glabrata, C. guilliermondii and C. inconspicua; however significant correlation with the presence of these yeasts in saliva was found (Waltimo et al. 1997, 2003; Baumgartner et al. 2000; Egan et al. 2002). C. albicans, as a dentinophilic species with an invasive affinity for the dentin smear layer and dental tubules, can form a complex biofilm in root canals. The possibility to dentin colonization provides yeasts access to nutrients and protects them from the action of antifungal drugs, thus these species becoming one of the causes of persistent cases of apical periodontitis (Siqueira and Sen 2004; Ghogre 2014). In addition to the C. albicans species, in root canals with pulp necrosis and periapical lesions, filamentous fungi of the genus Aspergillus , Penicillium, and Fusarium were also identified (Gomes et al. 2010, 2015); however, they have not yet been identified as dentinophilic species (Siqueira et al. 2002). Besides, the implant sites have been shown to provide an attractive microenvironment that fosters uncontrolled microbial biofilms (Øilo and Bakken 2015); however, the fungal profile depends on the implant’s clinical condition. C. dubliniensis and Cladosporium cladosporioides predominate in healthy implantation sites. In contrast, in samples taken from peri-implantation sites, dominate C. albicans, C. boidinii, Penicillium spp., R. laryngis, Paecilomyces spp., Saccharomyces and Cl. cladosporioides. The coexistence of fungi with Parvimonas micra and Tannerella forsythia was found in healthy and diseased peri-implant sites (Schwarz et al. 2015).
One of the most important risk factors for periodontitis associated with environmental conditions and the chosen lifestyle is cigarette smoking (Tomar and Asma 2000). The samples of subgingival sites obtained from smokers with early-onset periodontitis were characterized by the noticeably higher incidence of bacterial periodontopathogens and fungi A. fumigatus and C. albicans (Kamma et al. 1999). Current research confirms the presence of other species of the Candida genus in the subgingival sites and saliva of smokers with chronic periodontitis, including C. krusei, C. tropicalis and C. glabrata (Santhana Krishnan et al. 2020). Moreover, it has been demonstrated that both cigarette smoke and e-cigarette vapor might significantly increase the overall virulence potential of C. albicans and enhance the adhesion of fungal cells to the gingival epithelial cells and fibroblasts, thereby increasing the pathogenicity of fungi during infections localized in the oral cavity and periodontium (Alanazi et al. 2014, 2019).
Other environmental factors may also contribute to the increased colonization of subgingival sites by Candida fungi, including changes in the hormonal balance caused by oral contraceptives. As reported by Brusca et al. (Brusca et al. 2010), the oral administration of ethinyl estradiol, gestodene, and drospirenone, combined with cigarette smoking, caused a statistically significant increase in the incidence of severe periodontitis, and under such conditions, different species of the genus Candida , including C. parapsilosis, C. glabrata, C. tropicalis, C. krusei, C. albicans, and C. guilliermondii were isolated from the gingival pockets. In most cases, yeast isolates were identified together with bacterial periodontal pathogens, such as Actinobacillus actinomycetemcomitans, Prevotella intermedia and Porphyromonas gingivalis (Brusca et al. 2010).
3 Virulence Factors Involved in the Fungal Invasion of Periodontal Tissue
The participation of fungi in the development of periodontal disease might be related to the exploitation of a number of virulence factors by fungal pathogens that allow them to efficacious adhesion to host tissues followed by their invasion and destruction as well as effective avoiding the host’s immune response (Fig. 6.2). The mechanisms related to the pathogenicity of fungi are based on the morphological polymorphism and the formation of adhesive filamentous forms, production of protective cellular envelopes, exposition of surface adhesins, biofilm formation and the ability of intercellular communication within it, enhancement of environmental stress resistance, and secretion of hydrolytic enzymes and toxins (Karkowska-Kuleta et al. 2009). Also, the coexistence of fungi with bacterial key periodontopathogens in the subgingival sites is considered as a factor contributing to the pathogenicity of fungi identified in the periodontal lesions (O’Donnell et al. 2015; Delaney et al. 2018).
3.1 Adhesion and Biofilm Formation
The adhesion of pathogen cells to the host tissues or the surface of artificial materials located in the oral cavity is one of the first and crucial steps in initiating colonization and further invasion by a microorganism (Nikawa et al. 2006). In fungi, there are several mechanisms associated with the enhancement in cell adhesiveness and surface hydrophobicity, including the presentation of a wide range of different adhesive proteins and N-linked glycans on their cell surface (Glee et al. 1995; Masuoka and Hazen 2004; El-Kirat-Chatel et al. 2015; Hoyer and Cota 2016). These properties are also associated with the microbial ability to form biofilms as structures more resistant to adverse environmental conditions and the host’s immune system activity (Kucharíková et al. 2015; Silva-Dias et al. 2015).
The most frequently described yeast adhesins, that are typically multidomain proteins equipped with N- and O-linked polysaccharide chains and a glycosylphosphatidylinositol (GPI) anchor, are agglutinins and flocculins of S. cerevisiae, lectin-like Epa (epithelial adhesin) protein family of 17 members, six adhesins Awp (adhesin-like wall proteins) and seven Pwp proteins (PA14-containing wall protein) of C. glabrata and C. albicans adhesins from Als (agglutinin-like sequence) protein family consisting of eight members (Als1–7 and Als9), (Hoyer 2001; Verstrepen and Klis 2006; Dranginis et al. 2007; de Groot et al. 2008; Kraneveld et al. 2011; Timmermans et al. 2018). Other important C. albicans adhesins are Hwp1 (hyphal wall protein), Eap1 (enhanced adhesion to polystyrene), and Csh1 (cell surface hydrophobicity), while the latter is also indicated as essential for C. dubliniensis cell surface hydrophobicity and virulence (Singleton et al. 2001, 2005; Li and Palecek 2003; Hazen 2004; Naglik et al. 2006; Ene and Bennett 2009). In the case of C. albicans, C. parapsilosis and C. glabrata it was shown that cell surface hydrophobicity correlates with adhesion to human buccal epithelial cells and denture acrylic surfaces (Panagoda et al. 2001; Luo and Samaranayake 2002). Also, it was reported that cells of C. albicans strain, isolated from patients with chronic periodontitis and diabetes that showed high surface hydrophobicity had a greater ability to adhere and invade human gingival fibroblasts (Sardi et al. 2012b).
The change in the morphological form and the formation of hyphae, on which surface typical adhesive proteins are abundantly exposed, may also increase the adhesiveness of Candida yeasts (Kumamoto and Vinces 2005; Tronchin et al. 2008; Mayer et al. 2013). Hyphal growth of C. albicans cells was previously considered as essential for penetration into gingival tissues in chronic periodontitis (Jarvensivu et al. 2004). The cigarette smoke condensate promoted the hyphae formation by C. albicans, increased expression of HWP1 and EAP1 genes, biofilm-forming ability, and fungal adhesion to human gingival fibroblasts, whereas e-cigarette vapor stimulated the binding of fungi to gingival epithelial cells and elongation of hyphae (Alanazi et al. 2014, 2019; Semlali et al. 2014).
In the case of A. fumigatus, the mechanisms of fungal adhesion are not sufficiently well understood. Initially, it was pointed out that some proteins of the conidia surface, including conidial hydrophobin RodA, 37-kDa allergen Asp f 2, and extracellular thaumatin domain protein (AfCalA) may bind to host ligands (Thau et al. 1994; Banerjee et al. 1998; Upadhyay et al. 2009). However, the major role in the adhesion of these fungi to plastic, fibronectin, intact basal lamina, and the epithelium is generally assigned to surface-exposed negatively charged carbohydrates and galactosaminogalactan (GAG) (Wasylnka and Moore 2000; Gravelat et al. 2013; Rambach et al. 2015).
3.2 Fungal Hydrolytic Enzymes and Toxins
The hydrolytic activity is essential for fungal pathogens to obtain nutrients, degrade host tissues and proteins during the invasion, and evade the immune system response. Therefore fungi secrete extracellularly or present on their cell surface a variety of hydrolytic enzymes, including lipases, phospholipases, phosphatases, proteases, and hemolysins (Barrett-Bee et al. 1985; Robinson et al. 1990; Monod et al. 1994; Hube et al. 2000; Luo et al. 2001; Wartenberg et al. 2011).
One of the groups of yeast hydrolases that have been most thoroughly described regarding their involvement in the pathogenesis is secreted aspartic proteinases (Sap). Two catalytic Asp residues being a part of an Asp-Ser-Gly/Asp-Thr-Gly motif are responsible for the Sap hydrolytic activity at acidic pH as optimal (Koelsch et al. 2000; Rapala-Kozik et al. 2018). In the case of C. albicans, there are identified ten members of the SAP gene family (SAP1–10), three for C. parapsilosis (SAPP1–3), and four for C. tropicalis proteinases (SAPT1–4) (Zaugg et al. 2001; Hube and Naglik 2001; Singh et al. 2019). The broad substrate specificity of Saps ensures the participation of these proteins not only in the acquisition of nutrients, adhesion, and tissue damage but also additionally in many processes related to the interaction with host proteins, including the degradation of antimicrobial peptides, the modulation of inflammatory state or the deactivation of the complement system (Villar et al. 2007; Gropp et al. 2009; Bras et al. 2012, 2013; Kozik et al. 2015; Svoboda et al. 2015; Bochenska et al. 2015, 2016; Yu et al. 2016; Singh et al. 2019). The genome of C. glabrata contains at least 11 genes encoding yapsins (YPS)—extracellular glycosylphosphatidylinositol-linked aspartyl proteases also involved in fungal adhesion, virulence and cell wall maintenance (Kaur et al. 2007; Rasheed et al. 2018).
Other pathogenic fungi—A. fumigatus also produce aspartyl proteinases, including 38 kDa Pep1 protein (Reichard et al. 1994), 32 kDa serine protease Alp1 (Reichard et al. 1990) and metalloproteinase Mep1 (Shende et al. 2018). The latter two were identified as responsible for the degradation of the complement system components (Behnsen et al. 2010; Shende et al. 2018).
Apart from proteolytic activity, also other hydrolytic enzymes are essential for fungal virulence. In C. albicans, such enzymes also include the lipase family consisting of 10 members (LIP1–10) (Hube et al. 2000) and different phospholipases. Of the Candida family of phospholipases, the best described is the extracellular phospholipase Plb1—a lipolytic enzyme considered as an important virulence factor of C. albicans (Leidich et al. 1998; Hruskova-Heidingsfeldova 2008). Phospholipase activity was also detected for A. fumigatus, and assigned for proteins afPLB1, afPLB3, and phospholipase D (Shen et al. 2004; Li et al. 2012). Furthermore, for pathogenic representatives of different fungal genera, extracellular hemolytic activity is very important in virulence since it allows them to obtain iron from host erythrocytes in the infectious site (Manns et al. 1994; Luo et al. 2001; Kaveemongkonrat et al. 2019).
In addition to enzymatic proteins, also toxins play a significant role in the pathogenesis of fungal infections. C. albicans secreted cytolytic toxin—candidalysin, which is released from the Ece1 (extent of cell elongation) protein by the Golgi-located Kex2 protease, has been identified recently as one of the key virulence factors (Moyes et al. 2016). This secreted candidal toxin is involved in the direct damage of the epithelial cells by their permeabilization but can also activate pro-inflammatory host protection by mononuclear phagocytes (Naglik et al. 2019; König et al. 2020).
A wide variety of toxins are produced also by fungi other than Candida species, including A. fumigatus, for which several toxic secondary metabolites have been shown to contribute significantly to fungal pathogenicity (Rementeria et al. 2005). Among the best described mycotoxins of A. fumigatus are gliotoxin and fumagillin. Gliotoxin is an immunosuppressive and cytotoxic molecule highly affecting fungal virulence and responsible for the inhibition of the respiratory burst and phagocytosis, and the stimulation of apoptosis in leukocytes (Reeves et al. 2004; Sugui et al. 2007; Gayathri et al. 2020). Whereas fumagillin exhibits antiangiogenic properties through the irreversible inhibition of methionine aminopeptidase (MetAP) type 2 (Sin et al. 1997), it has also the ability to reduce the activity of neutrophils (Fallon et al. 2010) and is involved in the damage of the epithelial cells during infection (Guruceaga et al. 2018).
3.3 Fungal—Host Interactions
C. albicans Als3 protein enables effective invasion of the oral epithelium through binding to E-cadherin, cell adhesion molecule forming adherens junctions (Phan et al. 2007). Such interaction induces microfilament rearrangement, which activates hyphal endocytosis through the endothelial layer, allowing the invasion of tissues (Phan et al. 2007). It has been shown that the contact of fungal adhesins with gingival fibroblasts induces the production of proinflammatory factors such as tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), interleukin 13 (IL-13) by the activation of toll-like receptor 2 (TLR2) expressed on the cell surface (Pinheiro et al. 2018). Additionally, data presented by Sardi et al. indicated that gingival fibroblasts respond to fungal adhesion by producing nitric oxide (NO). A high concentration of NO in the microenvironment of periodontal disease may have a cytotoxic and cytostatic effect against infected cells and results in rapid tissue damage (Sardi et al. 2012b).
Adhesion to the surface of host proteins is a critical step in the initiation of biofilm formation (Phan et al. 2007). The appearance of such complex structures is a considerable challenge for the immune system, and the host cell response is closely dependent on the phase of biofilm development. At the initial stage of infection, access to the fungal cells is easier, and the immune system is effectively activated, mostly by recognizing the elements of the microbial cell wall or the secreted proteins. However, to date, several examples of the attenuation of the host cell’s innate response to mature biofilm infections have been described. The main barrier that effectively hinders contact of the immune system with pathogen cells is the dense extracellular matrix (ECM) layer surrounding the mature biofilm (Sandai et al. 2016). Neutrophils, the first white blood cells recruited to the infection site, are equipped with several killing mechanisms, among which the most important in the context of fighting extensive fungal infections is the netosis process (Urban et al. 2006, 2009). During netosis, activated neutrophils release decondensed chromatin fibers, decorated with antimicrobial proteins derived from granules (NET) (Brinkmann et al. 2004). The research revealed that netosis is an effective mechanism to prevent invasion by large-size microorganisms that are relatively difficult to neutralize by phagocytosis (Branzk et al. 2014), including the filamentous forms of Candida and Aspergillus spp. Johnson et al. indicated that contact of neutrophils with C. albicans biofilm impairs NET release, making biofilm more resistant to neutrophil attack (Johnson et al. 2016). This inhibitory effect appears to be related to the presence of a high concentration of polysaccharides—the main components of ECM. It has been shown that C. albicans biofilms also resist attack by monocytes. Studies conducted on monocyte-like cell line THP-1 indicated the downregulation of TNF-α production, compared to planktonic cells (Katragkou et al. 2010). Inhibition of the production of this cytokine contributes to a significant reduction of phagocytosis. Taking into consideration that TNF-α has been shown to directly inhibit C. albicans biofilm formation by interaction with N,N′-diacetylchitobiose, this mechanism may represent an evolutionary adaption of fungal biofilm to immune system evasion (Kernien et al. 2017; Rocha et al. 2017). Similar results, indicating a protective role of ECM, were obtained for Aspergillus biofilms. In this case, the ECM’s most essential components are galactomannan and GAG (Loussert et al. 2010). The secreted enzyme Agd3 deacetylates these ECM components. Such modification is a critical step in forming A. fumigatus biofilms, ensuring the adhesion to anionic surfaces, including host tissues (Lee et al. 2016). Moreover, cell wall-bound GAG has been shown to influence the resistance of Aspergillus to neutrophil killing, probably by inhibition of NET binding to hyphae (Lee et al. 2015).
The main consequence of fungal proteolytic activity for a broad spectrum of host peptides and proteins, including lactoferrin, lactoperoxidase, cathepsin D, albumin, hemoglobin, LL37, histatin, contact system components, and the extracellular matrix proteins (Naglik et al. 2003; Rapala-Kozik et al. 2010, 2015) is their hydrolysis by Saps. Sap1–3 has been shown to degrade complement components preventing yeast opsonization and phagocytosis (Gropp et al. 2009). Saps are also the main fungal proteins involved in the penetration of the epithelium layer through the degradation of E-cadherin, mainly due to the activity of Sap5, which contributes to the destruction of host tissues (Villar et al. 2007). These enzymes might also activate the innate immune response. It has been indicated that Saps exhibit strong chemoattractant properties and drive the influx of neutrophils and macrophages to the place of infection and these proinflammatory properties are rather independent of proteolytic activity (Pietrella et al. 2010; Gabrielli et al. 2016). Through the activation of Akt/NF-κB pathway, Saps activate the expression of a broad spectrum of cytokines such as IL-1β, IL-6, and TNF-α (Pietrella et al. 2010).
Furthermore, Saps are involved in the activation of ROS generation and have the potential to induce NET formation (Hornbach et al. 2009; Zawrotniak et al. 2017). This mechanism may be of particular importance in the context of effective protection against oral infections, as it has been shown that neutrophils isolated from the peripheral blood and gingival crevice from individuals with periodontitis have significantly reduced phagocytic properties (Asif and Kothiwale 2010). In contrast to Saps, the role of C. albicans phospholipases in pathogenesis is not so well elucidated. Phospholipases facilitate the adhesion of yeast to the tissue surface and degrade the components of biological membranes, which are mainly composed of phospholipids (Sardi et al. 2010).
Also, cadidalysin, the main toxin produced by C. albicans, plays a critical role in developing oral infections (Moyes et al. 2016; Pellon et al. 2020). Moyes et al. demonstrated for the first time that at the early stages of infection, this peptide induces a strong inflammatory response in epithelial cells, including the production of IL-6, IL-1 α/β, GM-CSF (granulocyte-macrophage colony-stimulating factor), G-CSF (granulocyte colony-stimulating factor), CCL20, antimicrobial peptides (β-defensins), and damage-associated molecular patterns (IL-1α and S100A8/9) via p-MKP1/c-Fos pathway (Moyes et al. 2010, 2014; Verma et al. 2017). Accumulation of candidalysin during the progression of the infection causes direct tissue damage through the mechanism of intercalation, permeabilization, and calcium influx (Moyes et al. 2016). The rapid release of IL-1α and its synergistic role with EGFR ligands on the innate activation of human oral epithelial cells being the effect of candidalysin was also confirmed (Hanaoka and Domae 2020) and it was proved that candidalysin induces the release of antimicrobial peptides hBD2, hBD3 and LL37 and epithelial alarmins ATP, ROS/RNS and S100A8 during oral yeast infection (Ho et al. 2020). Moreover, candidalysin-induced production of IL-1α/β drives the activation of a specialized subpopulation of lymphocytes TH17 expressing IL-17 (Verma et al. 2017). IL-17 production plays a crucial role in modulating the antifungal response (Mengesha and Conti 2017).
4 The Mixed-Species Biofilm Formation in the Periodontitis: Mechanism of Mutual Interactions Between Fungi and Bacteria
For many years, the common oral fungal colonizers were considered to be of minor importance in periodontal diseases. However, the observation that fungi can form multispecies biofilms with different types of bacteria has shed new light on the role of these microorganisms in periodontitis (Peters et al. 2017; Sultan et al. 2018; Delaney et al. 2018). The mixed-species microbial biofilm has a supragingival and subgingival location, where metabolic diversity encourages different species to aggregate and compete for space and nutrients (Aruni et al. 2015).
The formation of a polymicrobial community starts with the attachment of early colonizers to the tooth surface. The bacteria are represented by oral streptococci and Actinomyces species, which form the best environment for further appearance of bridging colonizers such as Fusobacterium nucleatum. Finally, the late colonizers—the red complex species: P. gingivalis , T. forsythia, and Treponema denticola find the best condition for existence, becoming the keystone species of periodontal disease (Könönen and Müller 2014; Mira et al. 2017; Manji et al. 2018; Valm 2019). Among them, P. gingivalis is also identified as a significant risk factor for developing cardiovascular disease (Oliveira et al. 2015), diabetes (Lamont et al. 2018), rheumatoid arthritis (Koziel et al. 2014), and Alzheimer’s or Parkinson’s diseases (Dominy et al. 2019; Olsen et al. 2020).
The biofilm cell mass is covered by an extracellular matrix that includes polysaccharides, lipids, and glycoproteins, not only of microbial but also of host origin. The biofilm matrix plays a unique role in protecting the formed microbial consortium against external factors, i.e. host defense factors, antioxidants, or antibiotics used in anti-biofilm therapies (Bowen et al. 2018).
During multispecies biofilm progression, identified fungal species can interact with bacteria, and the interactions may vary from synergism to competition or antagonism. Moreover, depending on the population diversity, opportunistic organisms, like yeasts belonging to Candida species, may switch from commensals to pathogens, equipped with an additional set of virulence factors. In periodontitis, the main synergistic microbial interactions were identified primarily for C. albicans, where fungal biofilm supports the milieu changes from aerobic to anaerobic (Fox et al. 2014), favoring the growth of Gram-negative obligate anaerobes. The microbial quorum-sensing molecules (QSM) or metabolic by-products may be useful in mutual pathogen communication. Moreover, the first colonizer’s primary host tissue infection may predispose host cells to facilitate colonization by the subsequent pathogen (Basavaraju et al. 2016). On the other hand, the competition between the interacting microbes for nutrition or binding sites can restrict early facultative aerobes’ growth, giving the late colonizer space for propagation.
The changes in the bacterial composition within mixed biofilm create a necessity for the lifestyle adaptation for fungi and modifying their interactions with emerging new bacterial partners. The different omic approaches supported the knowledge about the interactions and metabolic responses of microbial community members (Shokeen et al. 2021). These mutual microbial interactions can affect health or disease progression in the host organism. But the host activity can also impact the biofilm composition and the interplay between coexisting microbes by the immune system responses or divergences in the nutrient supply (Marsh and Zaura 2017; Lamont et al. 2018).
4.1 Synergistic Interactions
The mutual interaction of bacteria with fungi may be considered on two significant levels. The first one concerns the physical contact, where fungal filamentous cell morphotype (hyphae) serves as a structural platform for a mixed-species biofilm and plays a synergistic role. The second focuses on chemical and metabolic interactions and may also be antagonistic. In this case, the produced compounds modified the local environment’s properties by changing pH and oxygen availability and enabling bacterial development in unfavorable conditions. It also includes the action of QSM that might regulate the microbial morphology and population abundance (Marsh and Zaura 2017; Diaz and Valm 2020).
The mechanical stabilization of biofilms is carried out using non-specific physical interactions and specific protein-protein contact that facilitate microbes’ cooperation, especially in the teeth area, where pathogens are exposed to mechanical removal from the surface. Co-adhesion and co-aggregation ensure the proximity of microorganisms and enable collaboration within the mixed biofilm (Kolenbrander 2000). The important role of fungi in creating the specific interactions between microorganisms is related to the possible morphological changes of fungal cells, best documented for Candida yeasts, where formed elongated hyphae supported pathogens’ interactions within mixed biofilm structure (Cui et al. 2013; Diaz et al. 2014; Janus et al. 2016). The best-known relationships occurred between yeasts and the primary colonizers of oral cavity—streptococci (Diaz et al. 2012; Xu et al. 2014b), especially S. mutans and S. gordonii (Gross et al. 2012; Metwalli et al. 2013), where the fungi promote streptococcal biofilm formation, while streptococci enhance the invasive property of C. albicans (Diaz et al. 2012; Xu et al. 2014a). The synergistic physical co-existence between Streptococcus sp. and C. albicans leads to intimate corn-cobb-like structures in the supragingival sites (Zijnge et al. 2010) where S. gordonii promotes hyphal development of C. albicans cells. The adhesive contact between the microbes occurs due to specific protein-protein interactions in which the streptococcal cell surface adhesins CshA, SspA, and SspB are involved (Holmes et al. 1996; Silverman et al. 2010; Xu et al. 2014a). Fungal adhesins responsible for the recognition of streptococci are Hwp1 and the members of the Als protein family (Klotz et al. 2007; Bamford et al. 2009; Silverman et al. 2010). Additionally, the interactions between microorganisms are mediated by salivary proline-rich proteins, which adsorbed on the surface of S. gordonii may be recognized as receptors by C. albicans cells (Holmes et al. 1995; Bamford et al. 2009; Silverman et al. 2010).
Another example of an interplay between bacteria and fungi is the interaction of internalin-family surface protein—InIJ of P. gingivalis and C. albicans Als3 in the dental pockets (Sztukowska et al. 2018). The same fungal adhesin can also form complexes with the hemagglutinin domains of RgpA and Kgp—the major P. gingivalis cysteine proteinases—gingipains. Moreover, gingipains interact also with another C. albicans surface mannoprotein—Mp65, overproduced during contact with this bacterium, and important for hyphal morphogenesis, membrane cell wall organization, and fungal biofilm formation. An interesting relation was also observed for fungal enolase, a cytosolic protein that appears on the fungal cell surface as “moonlighting protein” (Satala et al. 2020a, b). The binding affinity between RgpA and enolase was even threefold higher than between RgpA and Als3 (Bartnicka et al. 2019).
The adhesion of P. gingivalis to fungal cells was also dependent on the activity of bacterial peptidylarginine deiminase (PPAD)—an enzyme that can perform the citrullination of both bacterial and fungal surface proteins. The decrease in interactions between these microorganisms, observed for the bacterial mutant strain with PPAD depletion, demonstrated the significant role of PPAD-mediated modification in these interactions (Karkowska-Kuleta et al. 2018).
Gingipains produced by P. gingivalis activate the host immune responses, but the host cell’s coinfection by bacteria and C. albicans cells leads to the alleviation of the inflammatory process, pointing to the possible protection of bacterial cells by fungal biofilm . Such a hypothesis was supported by the experiments performed using the mouse model, where the fungus initiated a sequential infection, and a reduction of mouse mortality was observed. On the other hand, mixed species biofilm assured more prolonged survival of bacteria within host tissues, suggesting the dual-species infection’s chronic nature (Bartnicka et al. 2020).
The interacting microorganisms are secured by the extracellular polysaccharide matrix (EPM) formed by both types of microbes (Xu et al. 2008). For example, S. mutans accompanied by C. albicans induces glucosyltransferase B (GtfB) gene (Falsetta et al. 2014), encoding enzyme that catalyzes the production of bacterial α-glucans. Their deposition on C. albicans cell surface leads to the expansion of mutual EPM and enhancing microbes adhesion (O’Sullivan et al. 2000; Falsetta et al. 2014; Hwang et al. 2017). Moreover, the presence of EPM is also beneficial for fungi, as EPM structures might trap an antifungal drug—fluconazole, thus protecting C. albicans from its effects (Kim et al. 2018). The mixed biofilm of C. albicans and S. gordonii can also be stabilized through the extracellular release of bacterial DNA (Jack et al. 2015).
The relationship between yeasts and bacteria related to metabolism and its by-products is an essential aspect of microbial cooperation responsible for the maintenance of appropriate environmental conditions and the proper development of biofilm above and below the gum line (Lof et al. 2017). Some specific adaptations of C. albicans metabolism to co-existence with S. gordonii were correlated with an increased expression of genes involved in fungal arginine biosynthesis, probably required to overcome the effects of the oxidative stress generated by these bacteria (Dutton et al. 2016).
In gingival pockets and dental canals, several bacteria are either facultative or obligate anaerobes. Maintaining a low oxygen concentration in such a milieu is essential for their proper growth and development. C. albicans survives in both aerobic and anaerobic conditions but possesses the ability to lower the local oxygen concentration (Fox et al. 2014; van Leeuwen et al. 2016; Janus et al. 2017), thus creates the conditions optimal for the development of a mixed-species biofilm with C. perfringens, B. fragilis, P. gingivalis , and C. difficile (Tamai et al. 2011; van Leeuwen et al. 2016; Karkowska-Kuleta et al. 2018).
4.2 Antagonistic Interactions
The interactions within the mixed biofilms depend on the fast adaptation to the coexisting microorganisms’ immediate needs and infection progression. The antagonistic relationships for microbes involved in periodontic diseases were again best documented for Candida species, especially for dominating C. albicans (Krüger et al. 2019).
For one of the first bacterial colonizers involved in these infections—streptococci, a synergistic collaboration with C. albicans was documented as contributing to plaque formation (Metwalli et al. 2013; Koo et al. 2018). But some contrary effects were also observed. The streptococci acidify the environment excreting carboxylic compounds, like lactate, pyruvate, or α-ketoglutarate. Nonetheless, low pH is unfavorable for fungal hyphae development. That finding was supported by observing the diminished formation of fungal hyphae in the Galleria mellonella larval tissue treated with S. mutans cell supernatant, resulting in the reduction of fungal cell pathogenicity. On the other hand, the cariogenic potential of S. mutans was attenuated in the biofilm formed with C. albicans cells, where higher pH was detected in comparison to one species, bacterial biofilm (Willems et al. 2016). C. albicans can use lactate as a carbon source for cell growth, thus alkalizing the environment, and maintaining a local pH at 5.3–5.5 (Vylkova et al. 2011; Krom et al. 2014; Danhof et al. 2016). Moreover, C. albicans is also able to generate ammonia, as a product of amino acid catabolism, increasing environmental pH and the hyphae formation (Vylkova et al. 2011). The alcalification of mixed biofilm milieu by fungi could be the way to counteract a microbial switch towards a cariogenic community and prevent the demineralization of teeth (Jenkinson et al. 1990).
Competition for access to limited nutrients may also affect the population dynamics within the biofilm . A good example is the heme competition between P. gingivalis and C. albicans, where at the restricted access to heme, the promotion of bacterial virulence was observed, correlated with the increase in expression of bacterial genes involved in heme utilization (Guo et al. 2020).
For antagonistic interactions, microbes also used the QSM production system (Barbosa et al. 2016). Such compounds include S. mutans signaling molecules like S-trans-2-decenoic acid, which is relevant in shaping multispecies fungal—bacteria biofilms, suppressing germ tube formation (Vílchez et al. 2010).
Another is the competence-stimulating peptide (CSP) produced during the early stages of S. mutans cell growth and fungal interaction with S. gordonii, influencing the fungal filamentation (Jarosz et al. 2009; Jack et al. 2015). A similar effect was also observed for mutanobactin A, that induced formation of yeast forms by C. albicans. Such inhibition of fungal cell filamentation may prevent activation of the immune system and proinflammatory cytokine production by macrophages (Joyner et al. 2010).
Other oral cavity bacteria—Streptococcus sanguinis presented antibacterial activity towards periodontal pathogens by the production of hydrogen peroxide and bacteriocin, which is localized within the S. sanguinis cells (Zhu and Kreth 2010). The hydrogen peroxide also influences fungal QSM—farnesol production and thus hyphae formation. On the other hand, the cell extract containing bacteriocin has antifungal activity and suppresses C. albicans and C. tropicalis cell growth (Ma et al. 2014).
C. albicans isolate from the root canal, and periapical infections are also accompanied with Enterococcus faecalis (Dahlén et al. 2012)—the opportunistic pathogenic bacterium also using bacteriocin (EntV), to inhibit fungal hyphal growth, biofilm formation, and virulence, without effect on cell viability (Cruz et al. 2013; Graham et al. 2017).
Another bacteria of aggressive periodontal disease—A. actinomycetemcomitans produces a different QSM—an autoinducer-2 (AI-2)—to inhibit C. albicans cell filamentation and suppress biofilm formation (Baker et al. 2017; Bachtiar et al. 2014). The genetic analysis of multispecies biofilm formed by A. actinomycetemcomitans showed the suppression of fungal hyphal-associated genes (ALS3 and HWP1) without any effect on gene representing yeast form (YWP1) (Bachtiar and Bachtiar 2020). However, the action of AI-2 released by S. gordonii presented an opposite effect on C. albicans cells, suggesting that different bacteria produce AI-2 derivates with a miscellaneous activity (Lof et al. 2017).
Antagonistic effects were also observed for C. albicans and C. dubliniensis collaborating with “bridging” bacteria—F. nucleatum, which is involved in colonization succession of the oral polymicrobial community (Grimaudo and Nesbitt 1997; Jabra-Rizk et al. 1999; Signat et al. 2011). The mutual influence of microbes is mediated by direct interaction between their surface proteins, fusobacterial membrane protein RadD and Candida cell wall protein Flo9 (Wu et al. 2015; Bor et al. 2016). Moreover, the supposed effects of their reduced virulence towards the host do not result from the secretion of regulatory particles or metabolic products. But they have the source in resulted inhibition of hyphal morphogenesis and fungal cell growth. It was proposed that the observed mutual attenuation of virulence may promote a rather commensal lifestyle of both biofilm-forming species (Bor et al. 2016).
4.3 The Periodontal Cells in the Face of Mixed Infections
With emerging evidence that the development of periodontitis is associated with the presence of both bacterial and fungal pathogens, understanding of the biological consequences of the cross-kingdom interactions of microbes for host response is crucial.
The most attention has been devoted to the model of mixed infections caused by P. gingivalis and C. albicans. In 2011 Tamai et al. demonstrated that heat-killed C. albicans, but also mannoprotein-β-glucan complex constituting a component of the yeast cell wall, enhanced invasion of human gingival fibroblasts and epithelial cells by P. gingivalis (Tamai et al. 2011). The mechanism underlying this phenomenon is unclear, but the authors put forward two hypotheses. Firstly, pretreatment with C. albicans or cell wall components promotes the recruitment of clathrin and clathrin-mediated invasion of host cells by P. gingivalis , more efficiently than by P. gingivalis alone. On the other hand, C. albicans induces trafficking of cell receptors such as toll-like receptors (TLRs) to lipid rafts, membrane microdomains involved in the entry of P. gingivalis into the epithelial cells (Tsuda et al. 2008; Tamai et al. 2011). Additionally, Haverman et al. observed that the interaction between P. gingivalis and Candida spp. (C. glabrata and C. kefyr) also lead to the inhibition of oral epithelial cell migration more than either pathogen separately (Tsuda et al. 2008).
Studies conducted on the human macrophage cell line (THP-1) have shown that contact with biofilm formed by P. gingivalis and C. albicans was characterized by a different level of production of the main proinflammatory cytokines—IL-1β, TNF-α and IL-8 (Bartnicka et al. 2020). The macrophage response to the supernatant obtained from a mono-species bacterial biofilm resulted in lower IL-1β production, compared to the reactions of THP-1 to C. albicans biofilm . Unexpectedly, the contact of THP cells with mixed biofilm resulted in a significant increase in IL-1β. On the other hand, a 24-h incubation of THP-1 with mixed biofilm caused a dramatic decrease in TNF-α and IL-8 levels compared to the treatment with mono-species biofilm . The reason for the observed changes in the level of cytokines may result from the activity of proteolytic enzymes produced by P. gingivalis . They can effectively degrade the cytokines produced by the host cells, impairing the immune response (Stathopoulou et al. 2009; Bartnicka et al. 2020), especially considering that their activity could be attenuated during contact with a fungal partner (Bartnicka et al. 2020). Another explanation might be that C. albicans cells prevent bacteria from being recognized by the immune cell receptors. Moreover, mixed biofilm also resulted in a reduced neutrophil response, as evidenced by a significantly lowered elastase activity compared to bacterial biofilm (Bartnicka et al. 2020).
An example of bacteria frequently co-isolated with C. albicans in periodontal pockets is F. nucleatum (Bor et al. 2016). In vitro studies have shown that their interaction retains C. albicans in morphology less sensitive to RAW macrophage killing. Moreover, the co-infection of C. albicans with F. nucleatum has been shown to inhibit the bacteria-induced production of proinflammatory molecules such as chemokine MCP-1 (monocyte chemoattractant protein 1) and cytokine TNF-α. The immune response’s attenuation was more effective when C. albicans was grown in yeast-like morphology (Bor et al. 2016).
5 New Trends in Prevention and Treatment of Periodontitis
The high incidence of periodontal diseases, the unsatisfactory effect of commonly used antibiotics, and the reports about the acquisition of drug resistance by pathogenic microorganisms present in the oral cavity necessitate the search for novel, alternative methods of preventing and treating periodontitis (Shlezinger et al. 2017; Cheng et al. 2017; Kinane et al. 2017). An additional problem in periodontal diseases caused by both bacterial and fungal pathogens is the accurate diagnosis and the correct identification of fungal microorganisms in subgingival sites and, consequently, the necessity for the modification of the conventional treatment. The diagnosis of fungal involvement in periodontal disease depends on the proper collection of a sample from the periodontal pockets after careful removal of the supragingival biofilm (Jewtuchowicz et al. 2008; Urzúa et al. 2008). Further diagnosis includes conventional fungal identification methods involving the observation of morphological changes or growth on differential media, however, a method based on the amplification of the internal transcribed spacer (ITS) is currently recommended (Persoon et al. 2017). In the case of the presence of fungi in the periodontal pockets during periodontitis, together with traditional treatment based on proper oral hygiene, conventional periodontal therapy , the use of topical antiseptics, and systemic antibiotics, the use of antifungals should be considered, including nystatin or fluconazole (Sardi et al. 2011a). Oral administration of antifungal drugs from other classes might also be required (De-la-Torre et al. 2017).
However, in view of the emerging resistance of pathogens in the biofilm (Sardi et al. 2011a; Jarvensivu et al. 2004), attempts are made to develop therapeutics based on microbial virulence mechanisms and targeted at specific pathogenic species. One of the attractive targets are P. gingivalis cysteine proteases—Rgp and Kgp, which play a significant role in developing periodontal diseases. It was reported that extract of Aspergillus oryzae S-03 grown on fat-free soybean inhibits P. gingivalis cell growth through gingipain inhibitors, probably derived from the digestion of soybeans by the A. oryzae protease (Danshiitsoodol et al. 2014). Another natural secondary bioactive metabolite is terrein from Aspergillus terreus. It has been shown that this compound inhibits osteoclastogenesis and related excessive bone resorption, correlated with periodontitis, by blocking the main osteoclast regulator’s activity—the activated cytoplasmic T cell nuclear factor 1. It was postulated that synthetic terrein, due to its low molecular mass and short half-life, might be used as an oral agent to prevent periodontal diseases (Nakagawa et al. 2020). There were also reports on the secretion of substances inhibiting bacterial and fungal growth by Malassezia and Pichia species. M. globosa spent medium has been shown to have antibacterial properties against S. mutans and S. mitis (Baraniya et al. 2020), while Pichia spent medium inhibits the growth of Candida , Aspergillus , and Fusarium (Mukherjee et al. 2014).
Another promising treatment in the fight against periodontitis is antisense therapy based on the peptide, which may block the synthesis of microbial proteins due to their strong affinity for mRNA. It was reported that the use of antisense peptides effectively inhibits the growth of two pathogens associated with periodontitis, P. gingivalis , and A. actinomycetemcomitans (Sugimoto et al. 2019). Similarly, the use of cerium-doped nanoparticles also inhibits the P. gingivalis and F. nucleatum. The acidic environment of the gingival pockets of patients with chronic periodontitis promotes the hydrolysis of nanoparticles, which releasing of ions modulate the microenvironment’s pH, consequently changing them to unfavorable for bacterial growth (Li et al. 2019). In turn, polylactic-co-glycolic acid (PLGA) nanoparticles, coated with a peptide derived from S. gordonii significantly reduce the virulence of P. gingivalis in a mouse model of periodontitis and strongly inhibit the adhesion of P. gingivalis to streptococci, preventing mixed infections (Mahmoud et al. 2019).
Potential candidates for alternative therapy are also sought among natural substances. For example, it has been shown that alcoholic red propolis extract has antifungal activity against Candida species isolated from patients with chronic periodontitis (Siqueira et al. 2015), while cardamom extract is bactericidal against periodontal pathogens—P. gingivalis , F. nucleatum, A. actinomycetemcomitans , and P. intermedia (Souissi et al. 2020).
6 Conclusion and Perspectives
Dental biofilm , where diverse microbes form a compact structure of biofilm , could be, in states of dysbiosis, the primary source of dental caries and periodontal diseases, which can further implicate systemic diseases by translocation the included microbes by the bloodstream into a variety of host tissues.
Although biofilm-forming microbes sustain their repertoires of virulence factors, the interaction with the environment and surrounding microbes, often from different species, gives rise to the emergent new properties of the microbial community.
Here we highlighted the role of fungal species forming biofilm with periodontal bacteria, where physical, metabolic, and chemical interactions shape their properties. Although there is evidence of the presence of particular representatives of various fungal genera—including Candida , Aspergillus , and Rhodotorula—in the subgingival biofilm of patients with severe chronic periodontitis, the most data are available for C. albicans. Numerous studies show that fungi are not an infection bystander but also an active member of the biofilm consortium. Fungal dimorphism and extracellular matrix, varied in the composition, may serve as bacterial shelter from the adverse environment or camouflage from host recognition, where synergistic or antagonistic interactions are presented. The understanding of cross-kingdom interplay that underlies the biofilm functioning, especially during contact with host cells, raises the need to search for new infection models that will enable the analysis of such diverse interactions. To meet this challenge, the development of organoids and organ-on-chip technology is the priority. It will create an opportunity to develop improved patient treatment strategies without the risk of infection recurrence.
Abbreviations
- Als:
-
Agglutinin-like sequence protein family
- ECM:
-
Extracellular matrix
- EPM:
-
Extracellular polysaccharide matrix
- GAG:
-
Galactosaminogalactan
- G-CSF:
-
Granulocyte colony-stimulating factor
- GM-CSF:
-
Granulocyte-macrophage colony-stimulating factor
- Hwp1:
-
Hyphal wall protein 1
- NET:
-
Neutrophil extracellular trap
- NO:
-
Nitric oxide
- ROS:
-
Reactive oxygen species
- Sap:
-
Secreted aspartic proteinase
- TLR:
-
Toll-like receptor
- TNF-α:
-
Tumor necrosis factor α
- QSM:
-
Quorum-sensing molecules
References
Aas JA, Barbuto SM, Alpagot T et al (2007) Subgingival plaque microbiota in HIV positive patients. J Clin Periodontol 34:189–195. https://doi.org/10.1111/j.1600-051X.2006.01034.x
Alanazi H, Semlali A, Perraud L et al (2014) Cigarette smoke-exposed Candida albicans increased chitin production and modulated human fibroblast cell responses. Biomed Res Int 2014:1–11. https://doi.org/10.1155/2014/963156
Alanazi H, Semlali A, Chmielewski W, Rouabhia M (2019) E-cigarettes increase Candida albicans growth and modulate its interaction with gingival epithelial cells. Int J Environ Res Public Health 16:294. https://doi.org/10.3390/ijerph16020294
Aruni AW, Dou Y, Mishra A, Fletcher HM (2015) The biofilm community-rebels with a cause. Curr Oral Heal Rep 2:48–56. https://doi.org/10.1007/s40496-014-0044-5
Asif K, Kothiwale S (2010) Phagocytic activity of peripheral blood and crevicular phagocytes in health and periodontal disease. J Indian Soc Periodontol 14:8. https://doi.org/10.4103/0972-124X.65427
Aslani N, Janbabaei G, Abastabar M et al (2018) Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry. BMC Infect Dis 18:24. https://doi.org/10.1186/s12879-017-2916-5
Babitha GA, Vangara A, Shobha P et al (2018) Candida albicans: can it be a periodontal pathogen? Int J Adv Res 6:1216–1225. https://doi.org/10.21474/IJAR01/6340
Bachtiar EW, Bachtiar BM (2020) Effect of cell-free spent media prepared from Aggregatibacter actinomycetemcomitans on the growth of Candida albicans and Streptococcus mutans in co-species biofilms. Eur J Oral Sci 128:395–404. https://doi.org/10.1111/eos.12725
Bachtiar EW, Bachtiar BM, Jarosz LM et al (2014) AI-2 of Aggregatibacter actinomycetemcomitans inhibits Candida albicans biofilm formation. Front Cell Infect Microbiol 4:94. https://doi.org/10.3389/fcimb.2014.00094
Baker JL, Bor B, Agnello M et al (2017) Ecology of the oral microbiome: beyond bacteria. Trends Microbiol 25:362–374. https://doi.org/10.1016/j.tim.2016.12.012
Bamford CV, D’Mello A, Nobbs AH et al (2009) Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect Immun 77:3696–3704. https://doi.org/10.1128/IAI.00438-09
Banerjee B, Greenberger PA, Fink JN, Kurup VP (1998) Immunological characterization of Asp f 2, a Major Allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis. Infect Immun 66:5175–5182. https://doi.org/10.1128/IAI.66.11.5175-5182.1998
Baraniya D, Chen T, Nahar A et al (2020) Supragingival mycobiome and inter-kingdom interactions in dental caries. J Oral Microbiol 12:1729305. https://doi.org/10.1080/20002297.2020.1729305
Barbosa JO, Rossoni RD, Vilela SFG et al (2016) Streptococcus mutans can modulate biofilm formation and attenuate the virulence of Candida albicans. PLoS One 11:e0150457. https://doi.org/10.1371/journal.pone.0150457
Barrett-Bee K, Hayes Y, Wilson RG, Ryley JF (1985) A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol 131:1217–1221. https://doi.org/10.1099/00221287-131-5-1217
Bartnicka D, Gonzalez-Gonzalez M, Sykut J et al (2020) Candida albicans shields the periodontal killer Porphyromonas gingivalis from recognition by the host immune system and supports the bacterial infection of gingival tissue. Int J Mol Sci 21:1984. https://doi.org/10.3390/ijms21061984
Bartnicka D, Karkowska-Kuleta J, Zawrotniak M et al (2019) Adhesive protein-mediated cross-talk between Candida albicans and Porphyromonas gingivalis in dual species biofilm protects the anaerobic bacterium in unfavorable oxic environment. Sci Rep 9:4376. https://doi.org/10.1038/s41598-019-40771-8
Basavaraju M, Sisnity VS, Palaparthy R, Addanki PK (2016) Quorum quenching: signal jamming in dental plaque biofilms. J Dent Sci 11:349–352. https://doi.org/10.1016/j.jds.2016.02.002
Bastos JA, Diniz CG, Bastos MG et al (2011) Identification of periodontal pathogens and severity of periodontitis in patients with and without chronic kidney disease. Arch Oral Biol 56:804–811. https://doi.org/10.1016/j.archoralbio.2010.12.006
Baumgardner DJ (2019) Oral fungal microbiota: to thrush and beyond. J Patient Cent Res Rev 6:252–261. https://doi.org/10.17294/2330-0698.1705
Baumgartner JC, Watts CM, Xia T (2000) Occurrence of Candida albicans in infections of endodontic origin. J Endod 26:695–698. https://doi.org/10.1097/00004770-200012000-00003
Behnsen J, Lessing F, Schindler S et al (2010) Secreted Aspergillus fumigatus protease Alp1 degrades human complement proteins C3, C4, and C5. Infect Immun 78:3585–3594. https://doi.org/10.1128/IAI.01353-09
Bochenska O, Rapala-Kozik M, Wolak N et al (2015) Inactivation of human kininogen-derived antimicrobial peptides by secreted aspartic proteases produced by the pathogenic yeast Candida albicans. Biol Chem 396:1369–1375. https://doi.org/10.1515/hsz-2015-0167
Bochenska O, Rapala-Kozik M, Wolak N et al (2016) The action of ten secreted aspartic proteases of pathogenic yeast Candida albicans on major human salivary antimicrobial peptide, histatin 5. Acta Biochim Pol 63:403–410. https://doi.org/10.18388/abp.2016_1318
Bor B, Cen L, Agnello M et al (2016) Morphological and physiological changes induced by contact-dependent interaction between Candida albicans and Fusobacterium nucleatum. Sci Rep 6:27956. https://doi.org/10.1038/srep27956
Bowen WH, Burne RA, Wu H, Koo H (2018) Oral biofilms: pathogens, matrix, and polymicrobial interactions in microenvironments. Trends Microbiol 26:229–242. https://doi.org/10.1016/j.tim.2017.09.008
Branzk N, Lubojemska A, Hardison SE et al (2014) Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat Immunol 15:1017–1025. https://doi.org/10.1038/ni.2987
Bras G, Bochenska O, Rapala-Kozik M et al (2012) Extracellular aspartic protease SAP2 of Candida albicans yeast cleaves human kininogens and releases proinflammatory peptides, Met-Lys-bradykinin and des-Arg(9)-Met-Lys-bradykinin. Biol Chem 393:829–839. https://doi.org/10.1515/hsz-2012-0157
Bras G, Bochenska O, Rapala-Kozik M et al (2013) Release of biologically active kinin peptides, Met-Lys-bradykinin and Leu-Met-Lys-bradykinin from human kininogens by two major secreted aspartic proteases of Candida parapsilosis. Peptides 48:114–123. https://doi.org/10.1016/j.peptides.2013.08.003
Brinkmann V, Reichard U, Goosmann C et al (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532–1535. https://doi.org/10.1126/science.1092385
Brusca MI, Rosa A, Albaina O et al (2010) The impact of oral contraceptives on women’s periodontal health and the subgingival occurrence of aggressive periodontopathogens and Candida species. J Periodontol 81:1010–1008. https://doi.org/10.1902/jop.2010.090575
Canabarro A, Valle C, Farias MR et al (2013) Association of subgingival colonization of Candida albicans and other yeasts with severity of chronic periodontitis. J Periodontal Res 48:428–432. https://doi.org/10.1111/jre.12022
Casanova L, Hughes FJ, Preshaw PM (2014) Diabetes and periodontal disease: a two-way relationship. Br Dent J 217:433–437. https://doi.org/10.1038/sj.bdj.2014.907
Cheng L, Zhang K, Zhang N et al (2017) Developing a new generation of antimicrobial and bioactive dental resins. J Dent Res 96:855–863. https://doi.org/10.1177/0022034517709739
Cruz MR, Graham CE, Gagliano BC et al (2013) Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans. Infect Immun 81:189–200. https://doi.org/10.1128/IAI.00914-12
Cui L, Morris A, Ghedin E (2013) The human mycobiome in health and disease. Genome Med 5:63. https://doi.org/10.1186/gm467
Dahlén G, Blomqvist S, Almståhl A, Carlén A (2012) Virulence factors and antibiotic susceptibility in enterococci isolated from oral mucosal and deep infections. J Oral Microbiol 4:10855. https://doi.org/10.3402/jom.v4i0.10855
Danhof HA, Vylkova S, Vesely EM et al (2016) Robust extracellular pH modulation by Candida albicans during growth in carboxylic acids. MBio 7:e01646-16. https://doi.org/10.1128/mBio.01646-16
Danshiitsoodol N, Yamashita H, Noda M et al (2014) Aspergillus oryzae S-03 produces gingipain inhibitors as a virulence factor for Porphyromonas gingivalis. J Bacteriol Virol 44:152. https://doi.org/10.4167/jbv.2014.44.2.152
de Groot PWJ, Kraneveld EA, Yin QY et al (2008) The cell wall of the human pathogen Candida glabrata: differential incorporation of novel adhesin-like wall proteins. Eukaryot Cell 7:1951–1964. https://doi.org/10.1128/EC.00284-08
Delaney C, Kean R, Short B et al (2018) Fungi at the scene of the crime: innocent bystanders or accomplices in oral infections? Curr Clin Microbiol Rep 5:190–200. https://doi.org/10.1007/s40588-018-0100-3
De-la-Torre J, Ortiz-Samperio ME, Marcos-Arias C et al (2017) In vitro antifungal susceptibility of oral Candida isolates from patients suffering from caries and chronic periodontitis. Mycopath 182(5-6):471–485. https://doi.org/10.1007/s11046-017-0112-1
De-la-Torre J, Quindós G, Marcos-Arias C et al (2018) Oral Candida colonization in patients with chronic periodontitis. Is there any relationship? Rev Iberoam Micol 35:134–139. https://doi.org/10.1016/j.riam.2018.03.005
Dewhirst FE, Chen T, Izard J et al (2010) The human oral microbiome. J Bacteriol 192:5002–5017. https://doi.org/10.1128/JB.00542-10
Diaz PI, Valm AM (2020) Microbial interactions in oral communities mediate emergent biofilm properties. J Dent Res 99:18–25. https://doi.org/10.1177/0022034519880157
Diaz PI, Xie Z, Sobue T et al (2012) Synergistic interaction between Candida albicans and commensal oral streptococci in a novel in vitro mucosal model. Infect Immun 80:620–632. https://doi.org/10.1128/IAI.05896-11
Diaz PI, Strausbaugh LD, Dongari-Bagtzoglou A (2014) Fungal-bacterial interactions and their relevance to oral health: linking the clinic and the bench. Front Cell Infect Microbiol 4:101. https://doi.org/10.3389/fcimb.2014.00101
Dominy SS, Lynch C, Ermini F et al (2019) Porphyromonas gingivalis in Alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv 5:eaau3333. https://doi.org/10.1126/sciadv.aau3333
Dranginis AM, Rauceo JM, Coronado JE, Lipke PN (2007) A biochemical guide to yeast adhesins: glycoproteins for social and antisocial occasions. Microbiol Mol Biol Rev 71:282–294. https://doi.org/10.1128/MMBR.00037-06
Dutton LC, Paszkiewicz KH, Silverman RJ et al (2016) Transcriptional landscape of trans-kingdom communication between Candida albicans and Streptococcus gordonii. Mol Oral Microbiol 31:136–161. https://doi.org/10.1111/omi.12111
Egan MW, Spratt DA, Ng Y-L et al (2002) Prevalence of yeasts in saliva and root canals of teeth associated with apical periodontitis. Int Endod J 35:321–329. https://doi.org/10.1046/j.1365-2591.2002.00478.x
El-Kirat-Chatel S, Beaussart A, Derclaye S et al (2015) Force nanoscopy of hydrophobic interactions in the fungal pathogen Candida glabrata. ACS Nano 9:1648–1655. https://doi.org/10.1021/nn506370f
Ene IV, Bennett RJ (2009) Hwp1 and related adhesins contribute to both mating and biofilm formation in Candida albicans. Eukaryot Cell 8:1909–1913. https://doi.org/10.1128/EC.00245-09
Fallon JP, Reeves EP, Kavanagh K (2010) Inhibition of neutrophil function following exposure to the Aspergillus fumigatus toxin fumagillin. J Med Microbiol 59:625–633. https://doi.org/10.1099/jmm.0.018192-0
Falsetta ML, Klein MI, Colonne PM et al (2014) Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo. Infect Immun 82:1968–1981. https://doi.org/10.1128/IAI.00087-14
Fechney JM, Browne GV, Prabhu N et al (2019) Preliminary study of the oral mycobiome of children with and without dental caries. J Oral Microbiol 11:1536182. https://doi.org/10.1080/20002297.2018.1536182
Fox EP, Cowley ES, Nobile CJ et al (2014) Anaerobic bacteria grow within Candida albicans biofilms and induce biofilm formation in suspension cultures. Curr Biol 24:2411–2416. https://doi.org/10.1016/j.cub.2014.08.057
Gabrielli E, Sabbatini S, Roselletti E et al (2016) In vivo induction of neutrophil chemotaxis by secretory aspartyl proteinases of Candida albicans. Virulence 5594. https://doi.org/10.1080/21505594.2016.1184385
Gayathri L, Akbarsha MA, Ruckmani K (2020) In vitro study on aspects of molecular mechanisms underlying invasive aspergillosis caused by gliotoxin and fumagillin, alone and in combination. Sci Rep 10:14473. https://doi.org/10.1038/s41598-020-71367-2
Ghannoum MA, Jurevic RJ, Mukherjee PK et al (2010) Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog 6:e1000713. https://doi.org/10.1371/journal.ppat.1000713
Ghogre P (2014) Endodontic mycology: a new perspective of root canal infection. RRJDS 1:43–50. e-ISSN: 2320-7949 and p-ISSN: 2322-0090
Glee PM, Sundstrom P, Hazen KC (1995) Expression of surface hydrophobic proteins by Candida albicans in vivo. Infect Immun 63:1373–1379. https://doi.org/10.1128/IAI.63.4.1373-1379.1995
Gomes C, Fidel S, Fidel R, de Moura Sarquis MI (2010) Isolation and taxonomy of filamentous fungi in endodontic infections. J Endod 36:626–629. https://doi.org/10.1016/j.joen.2010.01.016
Gomes CC, Pinto LCC, Victor FL et al (2015) Aspergillus in endodontic infection near the maxillary sinus. Braz J Otorhinolaryngol 81:527–532. https://doi.org/10.1016/j.bjorl.2015.07.013
Graham CE, Cruz MR, Garsin DA, Lorenz MC (2017) Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans. Proc Natl Acad Sci U S A 114:4507–4512. https://doi.org/10.1073/pnas.1620432114
Gravelat FN, Beauvais A, Liu H et al (2013) Aspergillus galactosaminogalactan mediates adherence to host constituents and conceals hyphal β-glucan from the immune system. PLoS Pathog 9:e1003575. https://doi.org/10.1371/journal.ppat.1003575
Grimaudo NJ, Nesbitt WE (1997) Coaggregation of Candida albicans with oral Fusobacterium species. Oral Microbiol Immunol 12:168–173. https://doi.org/10.1111/j.1399-302x.1997.tb00374.x
Gropp K, Schild L, Schindler S et al (2009) The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol Immunol 47:465–475. https://doi.org/10.1016/j.molimm.2009.08.019
Gross EL, Beall CJ, Kutsch SR et al (2012) Beyond Streptococcus mutans: dental caries onset linked to multiple species by 16S rRNA community analysis. PLoS One 7:e47722. https://doi.org/10.1371/journal.pone.0047722
Guo Y, Wang Y, Wang Y et al (2020) Heme competition triggers an increase in the pathogenic potential of Porphyromonas gingivalis in Porphyromonas gingivalis-Candida albicans mixed biofilm. Front Microbiol 11:596459. https://doi.org/10.3389/fmicb.2020.596459
Guruceaga X, Ezpeleta G, Mayayo E et al (2018) A possible role for fumagillin in cellular damage during host infection by Aspergillus fumigatus. Virulence 9:1548–1561. https://doi.org/10.1080/21505594.2018.1526528
Hammad MM, Darwazeh AMG, Idrees MM (2013) The effect of glycemic control on Candida colonization of the tongue and the subgingival plaque in patients with type II diabetes and periodontitis. Oral Surg Oral Med Oral Pathol Oral Radiol 116:321–326. https://doi.org/10.1016/j.oooo.2013.05.013
Hanaoka M, Domae E (2020) IL-1α released from oral epithelial cells upon candidalysin exposure initiates an early innate epithelial response. Int Immunol 33:dxaa070. https://doi.org/10.1093/intimm/dxaa070
Hazen KC (2004) Relationship between expression of cell surface hydrophobicity protein 1 (CSH1p) and surface hydrophobicity properties of Candida dubliniensis. Curr Microbiol 48:447–451. https://doi.org/10.1007/s00284-003-4223-1
Hellstein JW, Marek CL (2019) Candidiasis: red and white manifestations in the oral cavity. Head Neck Pathol 13:25–32. https://doi.org/10.1007/s12105-019-01004-6
Ho J, Wickramasinghe DN, Nikou SA et al (2020) Candidalysin is a potent trigger of alarmin and antimicrobial peptide release in epithelial cells. Cells 9:699. https://doi.org/10.3390/cells9030699
Holmes AR, Cannon RD, Jenkinson HF (1995) Interactions of Candida albicans with bacteria and salivary molecules in oral biofilms. J Ind Microbiol 15:208–213. https://doi.org/10.1007/BF01569827
Holmes ARR, McNab R, Jenkinson HFF (1996) Candida albicans binding to the oral bacterium Streptococcus gordonii involves multiple adhesin-receptor interactions. Infect Immun 64:4680–4685
Hornbach A, Heyken A, Schild L et al (2009) The glycosylphosphatidylinositol-anchored protease Sap9 modulates the interaction of Candida albicans with human neutrophils. Infect Immun 77:5216–5224. https://doi.org/10.1128/IAI.00723-09
Hou Y, Wang X, Zhang C-X et al (2017) Risk factors of periodontal disease in maintenance hemodialysis patients. Medicine (Baltimore) 96:e7892. https://doi.org/10.1097/MD.0000000000007892
Hoyer LL (2001) The ALS gene family of Candida albicans. Trends Microbiol 9:176–180. https://doi.org/10.1016/s0966-842x(01)01984-9
Hoyer LL, Cota E (2016) Candida albicans agglutinin-like sequence (Als) family vignettes: a review of als protein structure and function. Front Microbiol 7:280. https://doi.org/10.3389/fmicb.2016.00280
Hruskova-Heidingsfeldova O (2008) Secreted proteins of Candida albicans. Front Biosci 13:7227. https://doi.org/10.2741/3224
Hube B, Naglik J (2001) Candida albicans proteinases: resolving the mystery of a gene family. Microbiology 147:1997–2005. https://doi.org/10.1099/00221287-147-8-1997
Hube B, Stehr F, Bossenz M et al (2000) Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch Microbiol 174:362–374. https://doi.org/10.1007/s002030000218
Hwang G, Liu Y, Kim D et al (2017) Candida albicans mannans mediate Streptococcus mutans exoenzyme GtfB binding to modulate cross-kingdom biofilm development in vivo. PLoS Pathog 13:1–25. https://doi.org/10.1371/journal.ppat.1006407
Jabra-Rizk MA, Falkler WA, Merz WG et al (1999) Coaggregation of Candida dubliniensis with Fusobacterium nucleatum. J Clin Microbiol 37:1464–1468
Jack AA, Daniels DE, Jepson MA et al (2015) Streptococcus gordonii comCDE (competence) operon modulates biofilm formation with Candida albicans. Microbiology 161:411–421. https://doi.org/10.1099/mic.0.000010
Janus MM, Willems HME, Krom BP (2016) Candida albicans in multispecies oral communities; a keystone commensal? In: Advances in experimental medicine and biology. Springer, Dordrecht, pp 13–20
Janus MM, Crielaard W, Volgenant CMC et al (2017) Candida albicans alters the bacterial microbiome of early in vitro oral biofilms. J Oral Microbiol 9:1–10. https://doi.org/10.1080/20002297.2016.1270613
Jarosz LM, Deng DM, van der Mei HC et al (2009) Streptococcus mutans competence-stimulating peptide inhibits Candida albicans hypha formation. Eukaryot Cell 8:1658–1664. https://doi.org/10.1128/EC.00070-09
Jarvensivu A, Hietanen J, Rautemaa R et al (2004) Candida yeasts in chronic periodontitis tissues and subgingival microbial biofilms in vivo. Oral Dis 10:106–112. https://doi.org/10.1046/j.1354-523X.2003.00978.x
Javed F, Klingspor L, Sundin U et al (2009) Periodontal conditions, oral Candida albicans and salivary proteins in type 2 diabetic subjects with emphasis on gender. BMC Oral Health 9:12. https://doi.org/10.1186/1472-6831-9-12
Jenkinson HF, Lala HC, Shepherd MG (1990) Coaggregation of Streptococcus sanguis and other streptococci with Candida albicans. Infect Immun 58:1429–1436
Jewtuchowicz VM, Mujica MT, Brusca MI et al (2008) Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina. Oral Microbiol Immunol 23:505–509. https://doi.org/10.1111/j.1399-302X.2008.00465.x
Johansson A, Dahlén G (2018) Bacterial virulence factors that contribute to periodontal pathogenesis. In: Pathogenesis of periodontal diseases. Springer, Cham, pp 31–49
Johnson CJ, Cabezas-Olcoz J, Kernien JF et al (2016) The extracellular matrix of Candida albicans biofilms impairs formation of neutrophil extracellular traps. PLOS Pathog 12:e1005884. https://doi.org/10.1371/journal.ppat.1005884
Joyner PM, Liu J, Zhang Z et al (2010) Mutanobactin A from the human oral pathogen Streptococcus mutans is a cross-kingdom regulator of the yeast-mycelium transition. Org Biomol Chem 8:5486–5489. https://doi.org/10.1039/c0ob00579g
Kamma JJ, Nakou M, Baehni PC (1999) Clinical and microbiological characteristics of smokers with early onset periodontitis. J Periodontal Res 34:25–33. https://doi.org/10.1111/j.1600-0765.1999.tb02218.x
Kapellas K, Singh A, Bertotti M et al (2019) Periodontal and chronic kidney disease association: a systematic review and meta-analysis. Nephrology 24:202–212. https://doi.org/10.1111/nep.13225
Karkowska-Kuleta J, Rapala-Kozik M, Kozik A (2009) Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Acta Biochim Pol 56:211–224
Karkowska-Kuleta J, Bartnicka D, Zawrotniak M et al (2018) The activity of bacterial peptidylarginine deiminase is important during formation of dual-species biofilm by periodontal pathogen Porphyromonas gingivalis and opportunistic fungus Candida albicans. Pathog Dis 76:fty033. https://doi.org/10.1093/femspd/fty033
Katragkou A, Kruhlak MJ, Simitsopoulou M et al (2010) Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents. J Infect Dis 201:1941–1949. https://doi.org/10.1086/652783
Kaur R, Ma B, Cormack BP (2007) A family of glycosylphosphatidylinositol-linked aspartyl proteases is required for virulence of Candida glabrata. Proc Natl Acad Sci 104:7628–7633. https://doi.org/10.1073/pnas.0611195104
Kaveemongkonrat S, Duangsonk K, Houbraken J et al (2019) Partial characteristics of hemolytic factors secreted from airborne Aspergillus and Penicillium, and an enhancement of hemolysis by Aspergillus micronesiensis CAMP-like factor via Staphylococcus aureus-sphingomyelinase. J Microbiol 57:1086–1094. https://doi.org/10.1007/s12275-019-9133-4
Kernien JF, Snarr BD, Sheppard DC, Nett JE (2017) The interface between fungal biofilms and innate immunity. Front Immunol 8:1968. https://doi.org/10.3389/fimmu.2017.01968
Kim D, Liu Y, Benhamou RI et al (2018) Bacterial-derived exopolysaccharides enhance antifungal drug tolerance in a cross-kingdom oral biofilm. ISME J 12:1427–1442. https://doi.org/10.1038/s41396-018-0113-1
Kinane DF, Stathopoulou PG, Papapanou PN (2017) Periodontal diseases. Nat Rev Dis Prim 3:17038. https://doi.org/10.1038/nrdp.2017.38
Klotz SA, Chasin BS, Powell B et al (2007) Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn Microbiol Infect Dis 59:401–406. https://doi.org/10.1016/j.diagmicrobio.2007.07.001
Koelsch G, Tang J, Loy JA et al (2000) Enzymic characteristics of secreted aspartic proteases of Candida albicans. Biochim Biophys Acta Protein Struct Mol Enzymol 1480:117–131. https://doi.org/10.1016/S0167-4838(00)00068-6
Kolenbrander PE (2000) Oral microbial communities: biofilms, interactions, and genetic systems. Annu Rev Microbiol 54:413–437. https://doi.org/10.1146/annurev.micro.54.1.413
König A, Hube B, Kasper L (2020) The dual function of the fungal toxin candidalysin during Candida albicans-macrophage interaction and virulence. Toxins 12:469. https://doi.org/10.3390/toxins12080469
Könönen E, Müller H-P (2014) Microbiology of aggressive periodontitis. Periodontology 2000 65:46–78. https://doi.org/10.1111/prd.12016
Könönen E, Gursoy M, Gursoy UK (2019) Periodontitis: a multifaceted disease of tooth-supporting tissues. J Clin Med 8:1135. https://doi.org/10.3390/jcm8081135
Koo H, Andes DR, Krysan DJ (2018) Candida–streptococcal interactions in biofilm-associated oral diseases. PLOS Pathog 14:e1007342. https://doi.org/10.1371/journal.ppat.1007342
Koziel J, Mydel P, Potempa J (2014) The link between periodontal disease and rheumatoid arthritis: an updated review. Curr Rheumatol Rep 16:408. https://doi.org/10.1007/s11926-014-0408-9
Kozik A, Gogol M, Bochenska O et al (2015) Kinin release from human kininogen by 10 aspartic proteases produced by pathogenic yeast Candida albicans. BMC Microbiol 15:60. https://doi.org/10.1186/s12866-015-0394-8
Kraneveld EA, de Soet JJ, Deng DM et al (2011) Identification and differential gene expression of adhesin-like wall proteins in Candida glabrata biofilms. Mycopathologia 172:415–427. https://doi.org/10.1007/s11046-011-9446-2
Krom BP, Kidwai S, Ten Cate JM (2014) Candida and other fungal species: forgotten players of healthy oral microbiota. J Dent Res 93:445–451. https://doi.org/10.1177/0022034514521814
Krüger W, Vielreicher S, Kapitan M et al (2019) Fungal-Bacterial interactions in health and disease. Pathogens 8:70. https://doi.org/10.3390/pathogens8020070
Kucharíková S, Neirinck B, Sharma N et al (2015) In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model. J Antimicrob Chemother 70:846–856. https://doi.org/10.1093/jac/dku447
Kumamoto CA, Vinces MD (2005) Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence. Cell Microbiol 7:1546–1554. https://doi.org/10.1111/j.1462-5822.2005.00616.x
Lamont RJ, Koo H, Hajishengallis G (2018) The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol 16:745–759. https://doi.org/10.1038/s41579-018-0089-x
Lee MJ, Liu H, Barker BM et al (2015) The fungal exopolysaccharide galactosaminogalactan mediates virulence by enhancing resistance to neutrophil extracellular traps. PLoS Pathog 11:e1005187. https://doi.org/10.1371/journal.ppat.1005187
Lee MJ, Geller AM, Bamford NC et al (2016) Deacetylation of fungal exopolysaccharide mediates adhesion and biofilm formation. MBio 7:e00252–e00216. https://doi.org/10.1128/mBio.00252-16
Leidich SD, Ibrahim AS, Fu Y et al (1998) Cloning and disruption of ca PLB1, a phospholipase b gene involved in the pathogenicity of Candida albicans. J Biol Chem 273:26078–26086. https://doi.org/10.1074/jbc.273.40.26078
Li F, Palecek SP (2003) EAP1, a Candida albicans gene involved in binding human epithelial cells. Eukaryot Cell 2:1266–1273. https://doi.org/10.1128/EC.2.6.1266-1273.2003
Li X, Gao M, Han X et al (2012) Disruption of the phospholipase D gene attenuates the virulence of Aspergillus fumigatus. Infect Immun 80:429–440. https://doi.org/10.1128/IAI.05830-11
Li X, Qi M, Li C et al (2019) Novel nanoparticles of cerium-doped zeolitic imidazolate frameworks with dual benefits of antibacterial and anti-inflammatory functions against periodontitis. J Mater Chem B 7:6955–6971. https://doi.org/10.1039/C9TB01743G
Lof M, Janus MM, Krom BP (2017) Metabolic interactions between bacteria and fungi in commensal oral biofilms. J Fungi 3:40. https://doi.org/10.3390/jof3030040
Loussert C, Schmitt C, Prevost M-C et al (2010) In vivo biofilm composition of Aspergillus fumigatus. Cell Microbiol 12:405–410. https://doi.org/10.1111/j.1462-5822.2009.01409.x
Luo G, Samaranayake LP (2002) Candida glabrata, an emerging fungal pathogen, exhibits superior relative cell surface hydrophobicity and adhesion to denture acrylic surfaces compared with Candida albicans. APMIS 110:601–610. https://doi.org/10.1034/j.1600-0463.2002.1100902.x
Luo G, Samaranayake LP, Yau JYY (2001) Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol 39:2971–2974. https://doi.org/10.1128/JCM.39.8.2971-2974.2001
Ma S, Li H, Yan C et al (2014) Antagonistic effect of protein extracts from Streptococcus sanguinis on pathogenic bacteria and fungi of the oral cavity. Exp Ther Med 7:1486–1494. https://doi.org/10.3892/etm.2014.1618
Mahmoud MY, Steinbach-Rankins JM, Demuth DR (2019) Functional assessment of peptide-modified PLGA nanoparticles against oral biofilms in a murine model of periodontitis. J Control Release 297:3–13. https://doi.org/10.1016/j.jconrel.2019.01.036
Manji F, Dahlen G, Fejerskov O (2018) Caries and periodontitis: contesting the conventional wisdom on their aetiology. Caries Res 52:548–564. https://doi.org/10.1159/000488948
Manns JM, Mosser DM, Buckley HR (1994) Production of a hemolytic factor by Candida albicans. Infect Immun 62:5154–5156. https://doi.org/10.1128/IAI.62.11.5154-5156.1994
Marsh PD (2006) Dental plaque as a biofilm and a microbial community – implications for health and disease. BMC Oral Health 6:S14. https://doi.org/10.1186/1472-6831-6-S1-S14
Marsh PD, Zaura E (2017) Dental biofilm: ecological interactions in health and disease. J Clin Periodontol 44:S12–S22. https://doi.org/10.1111/jcpe.12679
Masuoka J, Hazen KC (2004) Cell wall mannan and cell surface hydrophobicity in Candida albicans serotype a and b strains. Infect Immun 72:6230–6236. https://doi.org/10.1128/IAI.72.11.6230-6236.2004
Matić Petrović S, Cimbaljević M, Radunović M et al (2015) Detection and sampling methods for isolation of Candida spp. from oral cavities in diabetics and non-diabetics. Braz Oral Res 29:1–7. https://doi.org/10.1590/1807-3107BOR-2015.vol29.0077
Matic Petrovic S, Radunovic M, Barac M et al (2019) Subgingival areas as potential reservoirs of different Candida spp in type 2 diabetes patients and healthy subjects. PLoS One 14:e0210527. https://doi.org/10.1371/journal.pone.0210527
Mayer FL, Wilson D, Hube B (2013) Candida albicans pathogenicity mechanisms. Virulence 4:119–128. https://doi.org/10.4161/viru.22913
Melton JJ, Redding SW, Kirkpatrick WR et al (2010) Recovery of Candida dubliniensis and other Candida species from the oral cavity of subjects with periodontitis who had well-controlled and poorly controlled type 2 diabetes: a pilot study. Spec Care Dentist 30:230–234. https://doi.org/10.1111/j.1754-4505.2010.00159.x
Mengesha B, Conti H (2017) The role of IL-17 in protection against mucosal Candida infections. J Fungi 3:52. https://doi.org/10.3390/jof3040052
Metwalli KH, Khan SA, Krom BP, Jabra-Rizk MA (2013) Streptococcus mutans, Candida albicans, and the human mouth: a sticky situation. PLoS Pathog 9:e1003616. https://doi.org/10.1371/journal.ppat.1003616
Mira A, Simon-Soro A, Curtis MA (2017) Role of microbial communities in the pathogenesis of periodontal diseases and caries. J Clin Periodontol 44(Suppl 1):S23–S38. https://doi.org/10.1111/jcpe.12671
Monod M, Togni G, Hube B, Sanglard D (1994) Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol Microbiol 13:357–368. https://doi.org/10.1111/j.1365-2958.1994.tb00429.x
Monteiro-da-Silva F, Araujo R, Sampaio-Maia B (2014) Interindividual variability and intraindividual stability of oral fungal microbiota over time. Med Mycol 52:498–505. https://doi.org/10.1093/mmy/myu027
Moyes DL, Runglall M, Murciano C et al (2010) A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells. Cell Host Microbe 8:225–235. https://doi.org/10.1016/j.chom.2010.08.002
Moyes DL, Shen C, Murciano C et al (2014) Protection against epithelial damage during Candida albicans infection is mediated by PI3K/Akt and mammalian target of rapamycin signaling. J Infect Dis 209:1816–1826. https://doi.org/10.1093/infdis/jit824
Moyes DL, Wilson D, Richardson JP et al (2016) Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature 532:64–68. https://doi.org/10.1038/nature17625
Mukherjee PK, Chandra J, Retuerto M et al (2014) Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi. PLoS Pathog 10:e1003996. https://doi.org/10.1371/journal.ppat.1003996
Murakami S, Mealey BL, Mariotti A, Chapple ILC (2018) Dental plaque-induced gingival conditions. J Periodontol 89:S17–S27. https://doi.org/10.1002/JPER.17-0095
Naglik JR, Challacombe SJ, Hube B (2003) Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 67:400–428. https://doi.org/10.1128/MMBR.67.3.400-428.2003
Naglik JR, Fostira F, Ruprai J et al (2006) Candida albicans HWP1 gene expression and host antibody responses in colonization and disease. J Med Microbiol 55:1323–1327. https://doi.org/10.1099/jmm.0.46737-0
Naglik JR, Gaffen SL, Hube B (2019) Candidalysin: discovery and function in Candida albicans infections. Curr Opin Microbiol 52:100–109. https://doi.org/10.1016/j.mib.2019.06.002
Nakagawa S, Omori K, Nakayama M et al (2020) The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1. Int Immunopharmacol 83:106429. https://doi.org/10.1016/j.intimp.2020.106429
Nikawa H, Egusa H, Makihira S et al (2006) An in vitro evaluation of the adhesion of Candida species to oral and lung tissue cells. Mycoses 49:14–17. https://doi.org/10.1111/j.1439-0507.2005.01176.x
Norhammar A, Kjellström B, Habib N et al (2019) Undetected dysglycemia is an important risk factor for two common diseases, myocardial infarction and periodontitis: a report from the PAROKRANK study. Diabetes Care 42:1504–1511. https://doi.org/10.2337/dc19-0018
O’Connell LM, Santos R, Springer G et al (2020) Site-specific profiling of the dental mycobiome reveals strong taxonomic shifts during progression of early-childhood caries. Appl Environ Microbiol 86:e02825–e02819. https://doi.org/10.1128/AEM.02825-19
O’Donnell LE, Millhouse E, Sherry L et al (2015) Polymicrobial Candida biofilms: friends and foe in the oral cavity. FEMS Yeast Res 15:fov077. https://doi.org/10.1093/femsyr/fov077
O’Sullivan JM, Jenkinson HF, Cannon RD (2000) Adhesion of Candida albicans to oral streptococci is promoted by selective adsorption of salivary proteins to the streptococcal cell surface. Microbiology 146:41–48. https://doi.org/10.1099/00221287-146-1-41
Øilo M, Bakken V (2015) Biofilm and dental biomaterials. Materials (Basel) 8:2887–2900. https://doi.org/10.3390/ma8062887
Oliveira FAF, Forte CPF, Silva PG de B et al (2015) Molecular analysis of oral bacteria in heart valve of patients with cardiovascular disease by real-time polymerase chain reaction. Medicine (Baltimore) 94:e2067. https://doi.org/10.1097/MD.0000000000002067
Olsen I, Kell DB, Pretorius E (2020) Is Porphyromonas gingivalis involved in Parkinson’s disease? Eur J Clin Microbiol Infect Dis 39:2013–2018. https://doi.org/10.1007/s10096-020-03944-2
Page RC, Kornman KS (1997) The pathogenesis of human periodontitis: an introduction. Periodontology 2000 14:9–11. https://doi.org/10.1111/j.1600-0757.1997.tb00189.x
Panagoda GJ, Ellepola ANB, Samaranayake LP (2001) Adhesion of Candida parapsilosis to epithelial and acrylic surfaces correlates with cell surface hydrophobicity. Mycoses 44:29–35. https://doi.org/10.1046/j.1439-0507.2001.00611.x
Pellon A, Sadeghi Nasab SD, Moyes DL (2020) New insights in Candida albicans innate immunity at the mucosa: toxins, epithelium, metabolism, and beyond. Front Cell Infect Microbiol 10:81. https://doi.org/10.3389/fcimb.2020.00081
Persoon IF, Buijs MJ, Özok et al (2017) The mycobiome of root canal infections is correlated to the bacteriome. Clin Oral Invest 21:1871–1881. https://doi.org/10.1007/s00784-016-1980-3
Peters BA, Wu J, Hayes RB, Ahn J (2017) The oral fungal mycobiome: characteristics and relation to periodontitis in a pilot study. BMC Microbiol 17:157. https://doi.org/10.1186/s12866-017-1064-9
Phan QT, Myers CL, Fu Y et al (2007) Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 5:e64. https://doi.org/10.1371/journal.pbio.0050064
Pietrella D, Rachini A, Pandey N et al (2010) The inflammatory response induced by aspartic proteases of Candida albicans is independent of proteolytic activity. Infect Immun 78:4754–4762. https://doi.org/10.1128/IAI.00789-10
Pinheiro CR, Coelho AL, de Oliveira CE et al (2018) Recognition of Candida albicans by gingival fibroblasts: the role of TLR2, TLR4/CD14, and MyD88. Cytokine 106:67–75. https://doi.org/10.1016/j.cyto.2017.10.013
Rambach G, Blum G, Latgé J-P et al (2015) Identification of Aspergillus fumigatus surface components that mediate interaction of conidia and hyphae with human platelets. J Infect Dis 212:1140–1149. https://doi.org/10.1093/infdis/jiv191
Rapala-Kozik M, Karkowska-Kuleta J, Ryzanowska A et al (2010) Degradation of human kininogens with the release of kinin peptides by extracellular proteinases of Candida spp. Biol Chem 391:823–830. https://doi.org/10.1515/BC.2010.083
Rapala-Kozik M, Bochenska O, Zawrotniak M et al (2015) Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans. Infect Immun 83:2518–2530. https://doi.org/10.1128/IAI.00023-15
Rapala-Kozik M, Bochenska O, Zajac D et al (2018) Extracellular proteinases of Candida species pathogenic yeasts. Mol Oral Microbiol 33:113–124. https://doi.org/10.1111/omi.12206
Rasheed M, Battu A, Kaur R (2018) Aspartyl proteases in Candida glabrata are required for suppression of the host innate immune response. J Biol Chem 293:6410–6433. https://doi.org/10.1074/jbc.M117.813741
Reeves EP, Messina CG, Doyle S, Kavanagh K (2004) Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella. Mycopathologia 158:73–79. https://doi.org/10.1023/b:myco.0000038434.55764.16
Reichard U, Buttner S, Eiffert H et al (1990) Purification and characterisation of an extracellular serine proteinase from Aspergillus fumigatus and its detection in tissue. J Med Microbiol 33:243–251. https://doi.org/10.1099/00222615-33-4-243
Reichard U, Eiffert H, Rüchel R (1994) Purification and characterization of an extracellular aspartic proteinase from Aspergillus fumigatus. Med Mycol 32:427–436. https://doi.org/10.1080/02681219480000581
Rementeria A, López-Molina N, Ludwig A et al (2005) Genes and molecules involved in Aspergillus fumigatus virulence. Rev Iberoam Micol 22:1–23. https://doi.org/10.1016/s1130-1406(05)70001-2
Reynaud AH, Nygaard-Østby B, Bøygard G-K et al (2001) Yeasts in periodontal pockets. J Clin Periodontol 28:860–864. https://doi.org/10.1034/j.1600-051x.2001.028009860.x
Robinson BW, Venaille TJ, Mendis AH, McAleer R (1990) Allergens as proteases: an Aspergillus fumigatus proteinase directly induces human epithelial cell detachment. J Allergy Clin Immunol 86:726–731. https://doi.org/10.1016/s0091-6749(05)80176-9
Rocha FAC, Alves AMCV, Rocha MFG et al (2017) Tumor necrosis factor prevents Candida albicans biofilm formation. Sci Rep 7:1206. https://doi.org/10.1038/s41598-017-01400-4
Sandai D, Tabana YM, Ouweini AE, Ayodeji IO (2016) Resistance of Candida albicans biofilms to drugs and the host immune system. Jundishapur J Microbiol 9:e37385. https://doi.org/10.5812/jjm.37385
Santhana Krishnan G, Naik D, Uppoor A et al (2020) Candidal carriage in saliva and subgingival plaque among smokers and non-smokers with chronic periodontitis-a cross-sectional study. PeerJ 8:e8441. https://doi.org/10.7717/peerj.8441
Sardi JCO, Duque C, Mariano FS et al (2010) Candida spp. in periodontal disease: a brief review. J Oral Sci 52:177–185. https://doi.org/10.2334/josnusd.52.177
Sardi JC, Almeida AM, Mendes Giannini MJ (2011a) New antimicrobial therapies used against fungi present in subgingival sites-a brief review. Arch Oral Biol 56:951–959. https://doi.org/10.1016/j.archoralbio.2011.03.007
Sardi JCO, Duque C, Camargo GACG et al (2011b) Periodontal conditions and prevalence of putative periodontopathogens and Candida spp. in insulin-dependent type 2 diabetic and non-diabetic patients with chronic periodontitis-a pilot study. Arch Oral Biol 56:1098–1105. https://doi.org/10.1016/j.archoralbio.2011.03.017
Sardi JCO, Duque C, Höfling JF, Gonçalves RB (2012a) Genetic and phenotypic evaluation of Candida albicans strains isolated from subgingival biofilm of diabetic patients with chronic periodontitis. Med Mycol 50:467–475. https://doi.org/10.3109/13693786.2011.633233
Sardi JCO, Duque C, Mariano FS et al (2012b) Adhesion and invasion of Candida albicans from periodontal pockets of patients with chronic periodontitis and diabetes to gingival human fibroblasts. Med Mycol 50:43–49. https://doi.org/10.3109/13693786.2011.586133
Satala D, Karkowska-Kuleta J, Zelazna A et al (2020a) Moonlighting proteins at the candidal cell surface. Microorganisms 8:1046. https://doi.org/10.3390/microorganisms8071046
Satala D, Satala G, Karkowska-Kuleta J et al (2020b) Structural insights into the interactions of candidal enolase with human vitronectin, fibronectin and plasminogen. Int J Mol Sci 21:7843. https://doi.org/10.3390/ijms21217843
Schelenz S, Abdallah S, Gray G et al (2011) Epidemiology of oral yeast colonization and infection in patients with hematological malignancies, head neck and solid tumors. J Oral Pathol Med 40:83–89. https://doi.org/10.1111/j.1600-0714.2010.00937.x
Schwarz F, Becker K, Rahn S et al (2015) Real-time PCR analysis of fungal organisms and bacterial species at peri-implantitis sites. Int J Implant Dent 1:9. https://doi.org/10.1186/s40729-015-0010-6
Semlali A, Killer K, Alanazi H et al (2014) Cigarette smoke condensate increases C. albicans adhesion, growth, biofilm formation, and EAP1, HWP1 and SAP2 gene expression. BMC Microbiol 14:61. https://doi.org/10.1186/1471-2180-14-61
Shen D-K, Noodeh AD, Kazemi A et al (2004) Characterisation and expression of phospholipases B from the opportunistic fungus Aspergillus fumigatus. FEMS Microbiol Lett 239:87–93. https://doi.org/10.1016/j.femsle.2004.08.019
Shende R, Wong SSW, Rapole S et al (2018) Aspergillus fumigatus conidial metalloprotease Mep1p cleaves host complement proteins. J Biol Chem 293:15538–15555. https://doi.org/10.1074/jbc.RA117.001476
Shi M, Wei Y, Hu W et al (2018a) The subgingival microbiome of periodontal pockets with different probing depths in chronic and aggressive periodontitis: a pilot study. Front Cell Infect Microbiol 8:124. https://doi.org/10.3389/fcimb.2018.00124
Shi Q, Zhang B, Xing H et al (2018b) Patients with chronic obstructive pulmonary disease suffer from worse periodontal health-evidence from a meta-analysis. Front Physiol 9:33. https://doi.org/10.3389/fphys.2018.00033
Shlezinger M, Khalifa L, Houri-Haddad Y et al (2017) Phage therapy: a new horizon in the antibacterial treatment of oral pathogens. Curr Top Med Chem 17:1199–1211. https://doi.org/10.2174/1568026616666160930145649
Shokeen B, Dinis MDB, Haghighi F et al (2021) Omics and interspecies interaction. Periodontology 2000 (85):101–111. https://doi.org/10.1111/prd.12354
Signat B, Roques C, Poulet P, Duffaut D (2011) Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol 13:25–36
Silva-Dias A, Miranda IM, Branco J et al (2015) Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp. Front Microbiol 6:205. https://doi.org/10.3389/fmicb.2015.00205
Silverman RJ, Nobbs AH, Vickerman MM et al (2010) Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixed-species communities. Infect Immun 78:4644–4652. https://doi.org/10.1128/IAI.00685-10
Sin N, Meng L, Wang MQ, Wen JJ, Bornmann WG, Crews CM (1997) The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci USA 94:6099–6103. https://doi.org/10.1073/pnas.94.12.6099
Singh DK, Németh T, Papp A et al (2019) Functional characterization of secreted aspartyl proteases in Candida parapsilosis. mSphere 4:e00484–e00419. https://doi.org/10.1128/mSphere.00484-19
Singleton DR, Masuoka J, Hazen KC (2001) Cloning and analysis of a Candida albicans gene that affects cell surface hydrophobicity. J Bacteriol 183:3582–3588. https://doi.org/10.1128/JB.183.12.3582-3588.2001
Singleton DR, Fidel PL, Wozniak KL, Hazen KC (2005) Contribution of cell surface hydrophobicity protein 1 (Csh1p) to virulence of hydrophobic Candida albicans serotype A cells. FEMS Microbiol Lett 244:373–377. https://doi.org/10.1016/j.femsle.2005.02.010
Siqueira JF Jr, Sen BH (2004) Fungi in endodontic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:632–641. https://doi.org/10.1016/S1079210404000046
Siqueira JF Jr, Rôças IN, Lopes HP et al (2002) Fungal infection of the radicular dentin. J Endod 28:770–773. https://doi.org/10.1097/00004770-200211000-00006
Siqueira ABS, Rodriguez LRN de A, Santos RKB et al (2015) Antifungal activity of propolis against Candida species isolated from cases of chronic periodontitis. Braz Oral Res 29:1–6. https://doi.org/10.1590/1807-3107BOR-2015.vol29.0083
Souissi M, Azelmat J, Chaieb K, Grenier D (2020) Antibacterial and anti-inflammatory activities of cardamom (Elettaria cardamomum) extracts: potential therapeutic benefits for periodontal infections. Anaerobe 61:102089. https://doi.org/10.1016/j.anaerobe.2019.102089
Stathopoulou PG, Benakanakere MR, Galicia JC, Kinane DF (2009) The host cytokine response to Porphyromonas gingivalis is modified by gingipains. Oral Microbiol Immunol 24:11–17. https://doi.org/10.1111/j.1399-302X.2008.00467.x
Sugimoto S, Maeda H, Kitamatsu M et al (2019) Selective growth inhibition of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans by antisense peptide nucleic acids. Mol Cell Probes 43:45–49. https://doi.org/10.1016/j.mcp.2018.11.006
Sugui JA, Pardo J, Chang YC et al (2007) Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone. Eukaryot Cell 6:1562–1569. https://doi.org/10.1128/EC.00141-07
Sultan AS, Kong EF, Rizk AM, Jabra-Rizk MA (2018) The oral microbiome: a lesson in coexistence. PLoS Pathog 14:e1006719. https://doi.org/10.1371/journal.ppat.1006719
Svoboda E, Schneider AE, Sándor N et al (2015) Secreted aspartic protease 2 of Candida albicans inactivates factor H and the macrophage factor H-receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18). Immunol Lett 168:13–21. https://doi.org/10.1016/j.imlet.2015.08.009
Sztukowska MN, Dutton LC, Delaney C et al (2018) Community development between Porphyromonas gingivalis and Candida albicans mediated by InlJ and Als3. mBio 9:e00202-18. https://doi.org/10.1128/mBio.00202-18
Tamai R, Sugamata M, Kiyoura Y (2011) Candida albicans enhances invasion of human gingival epithelial cells and gingival fibroblasts by Porphyromonas gingivalis. Microb Pathog 51:250–254. https://doi.org/10.1016/j.micpath.2011.06.009
Taylor GW, Manz MC, Borgnakke WS (2004) Diabetes, periodontal diseases, dental caries, and tooth loss: a review of the literature. Compend Contin Educ Dent 25:179–184, 186–8, 190
Thau N, Monod M, Crestani B et al (1994) Rodletless mutants of Aspergillus fumigatus. Infect Immun 62:4380–4388. https://doi.org/10.1128/IAI.62.10.4380-4388.1994
Timmermans B, De Las PA, Castaño I, Van Dijck P (2018) Adhesins in Candida glabrata. J Fungi 4:60. https://doi.org/10.3390/jof4020060
Tomar SL, Asma S (2000) Smoking-attributable periodontitis in the united states: findings from NHANES III. J Periodontol 71:743–751. https://doi.org/10.1902/jop.2000.71.5.743
Tronchin G, Pihet M, Lopes-Bezerra LM, Bouchara J-P (2008) Adherence mechanisms in human pathogenic fungi. Med Mycol 46:749–772. https://doi.org/10.1080/13693780802206435
Tsuda K, Furuta N, Inaba H et al (2008) Functional analysis of α5β1 integrin and lipid rafts in invasion of epithelial cells by Porphyromonas gingivalis using fluorescent beads coated with bacterial membrane vesicles. Cell Struct Funct 33:123–132. https://doi.org/10.1247/csf.08012
Upadhyay SK, Mahajan L, Ramjee S et al (2009) Identification and characterization of a laminin-binding protein of Aspergillus fumigatus: extracellular thaumatin domain protein (AfCalAp). J Med Microbiol 58:714–722. https://doi.org/10.1099/jmm.0.005991-0
Urban CF, Reichard U, Brinkmann V, Zychlinsky A (2006) Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol 8:668–676. https://doi.org/10.1111/j.1462-5822.2005.00659.x
Urban CF, Ermert D, Schmid M et al (2009) Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog 5:e1000639. https://doi.org/10.1371/journal.ppat.1000639
Urzúa B, Hermosilla G, Gamonal J et al (2008) Yeast diversity in the oral microbiota of subjects with periodontitis: Candida albicans and Candida dubliniensis colonize the periodontal pockets. Med Mycol 46:783–793. https://doi.org/10.1080/13693780802060899
Valm AM (2019) The structure of dental plaque microbial communities in the transition from health to dental caries and periodontal disease. J Mol Biol 431:2957–2969. https://doi.org/10.1016/j.jmb.2019.05.016
van Leeuwen PT, van der Peet JM, Bikker FJ et al (2016) Interspecies interactions between Clostridium difficile and Candida albicans. mSphere 1:e00187–e00116. https://doi.org/10.1128/mSphere.00187-16
Verma AH, Richardson JP, Zhou C et al (2017) Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin. Sci Immunol 2:eaam8834. https://doi.org/10.1126/sciimmunol.aam8834
Verstrepen KJ, Klis FM (2006) Flocculation, adhesion and biofilm formation in yeasts. Mol Microbiol 60:5–15. https://doi.org/10.1111/j.1365-2958.2006.05072.x
Vílchez R, Lemme A, Ballhausen B et al (2010) Streptococcus mutans inhibits Candida albicans hyphal formation by the fatty acid signaling molecule trans-2-decenoic acid (SDSF). Chembiochem 11:1552–1562. https://doi.org/10.1002/cbic.201000086
Villar CC, Kashleva H, Nobile CJ et al (2007) Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect Immun 75:2126–2135. https://doi.org/10.1128/IAI.00054-07
Vylkova S, Carman AJ, Danhof HA et al (2011) The fungal pathogen Candida albicans autoinduces hyphal morphogenesis by raising extracellular pH. MBio 2:e00055–e00011. https://doi.org/10.1128/mBio.00055-11
Wahid A, Chaudhry S, Ehsan A et al (2012) Bidirectional relationship between chronic kidney disease; periodontal disease: a review. Pakistan J Med Sci 29:211–215. https://doi.org/10.12669/pjms.291.2926
Waltimo TM, Sirén EK, Torkko HL et al (1997) Fungi in therapy-resistant apical periodontitis. Int Endod J 30:96–101. https://doi.org/10.1046/j.1365-2591.1997.00058.x
Waltimo TMT, Sen BH, Meurman JH et al (2003) Yeasts in apical periodontitis. Crit Rev Oral Biol Med 14:128–137. https://doi.org/10.1177/154411130301400206
Wartenberg D, Lapp K, Jacobsen ID et al (2011) Secretome analysis of Aspergillus fumigatus reveals Asp-hemolysin as a major secreted protein. Int J Med Microbiol 301:602–611. https://doi.org/10.1016/j.ijmm.2011.04.016
Wasylnka JA, Moore MM (2000) Adhesion of Aspergillus species to extracellular matrix proteins: evidence for involvement of negatively charged carbohydrates on the conidial surface. Infect Immun 68:3377–3384. https://doi.org/10.1128/IAI.68.6.3377-3384.2000
Willems HM, Kos K, Jabra-Rizk MA, Krom BP (2016) Candida albicans in oral biofilms could prevent caries. Pathog Dis 74:ftw039. https://doi.org/10.1093/femspd/ftw039
Wu T, Cen L, Kaplan C et al (2015) Cellular components mediating coadherence of Candida albicans and Fusobacterium nucleatum. J Dent Res 94:1432–1438. https://doi.org/10.1177/0022034515593706
Xu X-L, Lee RTH, Fang H-M et al (2008) Bacterial peptidoglycan triggers Candida albicans hyphal growth by directly activating the adenylyl cyclase Cyr1p. Cell Host Microbe 4:28–39. https://doi.org/10.1016/j.chom.2008.05.014
Xu H, Jenkinson HF, Dongari-Bagtzoglou A (2014a) Innocent until proven guilty: mechanisms and roles of Streptococcus-Candida interactions in oral health and disease. Mol Oral Microbiol 29:99–116. https://doi.org/10.1111/omi.12049
Xu H, Sobue T, Thompson A et al (2014b) Streptococcal co-infection augments Candida pathogenicity by amplifying the mucosal inflammatory response. Cell Microbiol 16:214–231. https://doi.org/10.1111/cmi.12216
Yu S, Li W, Liu X et al (2016) Distinct expression levels of ALS, LIP, and SAP genes in Candida tropicalis with diverse virulent activities. Front Microbiol 7:1175. https://doi.org/10.3389/fmicb.2016.01175
Zaugg C, Borg-von Zepelin M, Reichard U et al (2001) Secreted aspartic proteinase family of Candida tropicalis. Infect Immun 69:405–412. https://doi.org/10.1128/IAI.69.1.405-412.2001
Zawrotniak M, Bochenska O, Karkowska-Kuleta J et al (2017) Aspartic proteases and major cell wall components in Candida albicans trigger the release of neutrophil extracellular traps. Front Cell Infect Microbiol 7:414. https://doi.org/10.3389/fcimb.2017.00414
Zhao D, Khawaja AT, Jin L et al (2018) The directional and non-directional associations of periodontitis with chronic kidney disease: a systematic review and meta-analysis of observational studies. J Periodontal Res 53:682–704. https://doi.org/10.1111/jre.12565
Zhu L, Kreth J (2010) Role of Streptococcus mutans eukaryotic-type serine/threonine protein kinase in interspecies interactions with Streptococcus sanguinis. Arch Oral Biol 55:385–390. https://doi.org/10.1016/j.archoralbio.2010.03.012
Zijnge V, Van Leeuwen MBM, Degener JE et al (2010) Oral biofilm architecture on natural teeth. PLoS One 5:1–9. https://doi.org/10.1371/journal.pone.0009321
Acknowledgements
This work was supported in part by the National Science Centre of Poland (grant N° 2019/33/B/NZ6/02284 to M.R.-K.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Karkowska-Kuleta, J., Satala, D., Smolarz, M., Zawrotniak, M., Rapala-Kozik, M. (2022). Fungi—A Component of the Oral Microbiome Involved in Periodontal Diseases. In: Santi-Rocca, J. (eds) Periodontitis. Advances in Experimental Medicine and Biology, vol 1373. Springer, Cham. https://doi.org/10.1007/978-3-030-96881-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-96881-6_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-96880-9
Online ISBN: 978-3-030-96881-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)